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ABSTRACT 
 
Over the past decade, a new scientific discipline has emerged, integrating 
mechanics with biology to create complex engineered living systems. The building 
blocks – different cell types in an instructive environment – can be assembled in various 
ways to promote the emergence (or natural evolution and interaction) of the cells in a 
system with well-defined functionality. These functions could include sensing, 
information processing, protein expression, and actuation, among countless others. 
This Thesis presents a novel cellular system capable of actuation and fabricated 
using cells and hydrogels. A stereolithographic 3D printing technique (SLA) was used to 
create a hydrogel backbone made of a beam connecting two pillars that supports a muscle 
strip created from skeletal muscle cells in a fibrin-based matrix. The entire device is 
termed a “bio-bot,” or biological robot. Contraction of the cells within the muscle strip 
produced enough force to move the pillars and displace the bio-bot on a surface in a 
liquid medium. This Thesis is focused on the development and characterization 
(mechanical and biological) of the skeletal muscle-based biological actuator. 
The use of the SLA allowed for easy modifications of the polymerized part’s 
geometry and material properties. Increasing the energy dose of polymerization produced 
a stiffer beam that restricted bending and increased the passive tension in the muscle strip.  
15-19 days after cell seeding, the bio-bots displayed spontaneous contraction that resulted 
in a net displacement of up to ~6 mm in 10 minutes. During this time span, a maximum 
velocity of over 1890 µm/min was achieved. Future plans are focused on controlling the 
activity of the bio-bot using optogenetics. 
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1.  INTRODUCTION  
1.1 OVERVIEW AND SIGNIFICANCE 
Over the past decade, a new scientific discipline has emerged, integrating 
mechanics with biology to create complex engineered living systems. The building 
blocks – different cell types in an instructive environment – can be assembled in various 
ways to promote the emergence (or natural evolution and interaction) of the cells in a 
system with well-defined functionality. These functions could include sensing, 
information processing, protein expression, and actuation (Figure 1.1). 
 Scientists at the forefront of this research envision the extent of cellular and 
biological systems to include devices that are able to sense their surroundings and 
perform accordingly. Kamm et al. provide numerous examples of the cellular systems 
that can have real-world implications in medicine and the environment: 
• a biological “robot” or organism that has the ability to recognize a chemical 
gradient and produce a response, such as moving towards an oil spill for 
environmental remediation or neutralizing a dangerous toxin within the body; 
• an engineered “organ” to sense drug and protein levels or glucose concentration in 
the bloodstream and send the information to a feedback loop or insulin pump; 
• a micro-fluidic system acting as a human organ platform (heart, lung, or liver to 
eliminate harmful and costly drug development and testing; and 
• plants with neurons that can send out a signal for water or nutrients after sensing a 
local deficiency. 
All of these – and countless more – could potentially be achieved with the use of a 
few cell types, specifically neurons, endothelial cells, and muscle cells, which can be 
differentiated from stem cells (Kamm et al., 2010).   
 This Thesis presents a novel cellular system capable of actuation and fabricated 
using cells and hydrogels. A stereolithographic 3D printing technique was used to create 
a hydrogel backbone made of a beam connecting two pillars that supports a muscle strip 
made of skeletal muscle cells in a fibrin-based matrix. The entire device is termed a “bio-
bot,” or biological robot. Contraction of the cells within the muscle strip produced 
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enough force to move the pillars and displace the bio-bot on a surface in a liquid medium. 
This Thesis is focused on the development and characterization (mechanical and 
biological) of the skeletal muscle-based biological actuator. Future plans are focused on 
controlling the activity of the bio-bot using optogenetics. 
 
 
Figure 1.1: A Cellular System. Different cell types integrate and coordinate to form a cellular system 
(Kamm et al., 2010) 
1.2 SPECIFIC AIMS 
• Specific Aim 1: To engineer an autonomous, 3-dimensional biological actuator 
(bio-bot) using stereolithography. 
• Specific Aim 2: To optimize the design and performance of the device with 
biological and mechanical characterization of the bio-bot and muscle strip. 
• Specific Aim 3:  To achieve net locomotion of the bio-bot.  
1.3 ORGANIZATION OF THESIS 
This Thesis is organized as follows: Chapter 1 presents an overview, a discussion 
on the emergence of cellular systems, and a review of the Specific Aims. Chapter 2 
provides a broad literature review of the topics most relevant to this work: biological 
machines, 3D stereolithography, fibrin biomaterials, and skeletal muscle engineering. 
Chapter 3 outlines the protocols and materials used to carry out the aspects of this study, 
including fabrication, mechanical testing, cell culture, formation of the muscle strip, 
immunofluorescent analysis, and analysis of actuation. Chapter 4 presents the results of 
this study and offers a thoughtful discussion and analysis. Chapter 5 discusses potential 
future directions for the project and offers a broader perspective.  
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2. BACKGROUND AND LITERATURE REVIEW 
2.1  BIOLOGICAL MACHINES 
Biological machines are cellular systems with the ability to perform work.  They 
exist on all length scales, from an ATP synthase or a DNA replication enzyme, to a 
kinesin molecule walking along a microtubule, or an organ such as the kidney 
functioning as a factory. The 17-century life scientist Marcello Malpighi described 
nature’s way of operating the body as creating “a very large number of machines, which 
are of necessity made up of extremely minute parts so shaped and situated, such as to 
form a marvelous organ…” (Piccolino, 2000). Other scientists of this pre-industrial age 
adopted a similar view of the body’s physiological functions and mechanics being guided 
by principles similar to those driving man-made machines. Just as a machine in a factory 
required an energy source, a bodily machine was prompted into action by chemical, 
electrical, or mechanical stimuli. Scientists of today’s era have built on these notions to 
engineer a class of biological machines using cellular and molecular building blocks.  
 
2.1.1 SINGLE-MOLECULE AND SINGLE-CELL BIOLOGICAL MACHINES 
Bio-motors powered by molecules such as ATPase and kinesin have been used to 
transport actin filaments, microtubules, and micro posts (Clemmens et al., 2004; Noji et 
al., 1997; Soong et al., 2000). However, based on previous reports, a generated force 
greater than a few pN per molecule is not to be expected (Fisher & Kolomeisky, 1999). 
Biological machines driven by a few or a sheet of living cells can produce a greater force 
than that of molecular motors. Their mechanical properties can be exploited to produce 
actuation or fluid movement (with forces ranging from nano-Newtons to micro-Newtons) 
without the need for an exogenous energy source (Tanaka et al., 2007a).  
Simpler biological machines harness the power of one or a few cells such as 
microorganisms and cardiomyocytes. Itoh and colleagues used an electric potential 
gradient to control the motion of protozoa. Paramecium were directed to move objects 
through a culture medium with an output force of about 27 nN (Itoh, 2000). A unicellular 
photosynthetic algae guided by visible light (Chlamydomonas reinhardtii) produced 
enough power to transport 3 μm beads through a fluid with a velocity of over 100 μm/s 
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(Weibel et al., 2005). Finally, Hiratsuka et al. created a micro-motor by guiding bacteria 
along a circular track to spin a rotor (Hiratsuka et al., 2006).  
Morishima and colleagues created a micro-actuator that exploited the contraction 
of a few cardiomyocytes to displace arrays of hydrogel micro-pillars in a contractile force 
measurement system. The cellular machine was powered with exogenous glucose instead 
of electrical energy stimulus to bend the RGDS-coated PDMS pillars a maximum of 6 
μm with a force of only 80 pN (Morishima et al., 2006). Additionally, Kim and Park 
created a “hybrid cell motor” capable of actuating a micro-rotor by contractile forces of a 
few cardiomyocytes seeded in polymer micro-wells, with each producing an average 
force of 20 μN/well (Kim et al., 2006). However, movement of a larger structure or self-
powered autonomous device demands a higher force production and consequently a 
greater number of cells. Thus, the majority of biological machines are driven with a 
cluster or sheet of cells.  
2.1.2 BIOLOGICAL PUMPS 
One variety of biological machines is a pump that produces enough energy to 
move fluid, much as a heart valve or swimming organism can do. Tung et al. tethered a 
small number of flagellar motors to magnetic micro-beads and copper coils to generate 
AC power at about 1 mW/L. This system was also used as a microfluidic pump that 
employed the rotation of the tethered cells to produce a “fluidic conveyor belt” to move 
liquid across a channel (Tung & Kim, 2006). Many bio-actuating pumps have used 
cardiomyocyte sheets, which synchronously contract to produce a force. Tanaka et al. 
created a “pump on a microchip” in which cell sheet pulsation produced an oscillatory 
fluid motion within a micro-channel (Tanaka et al., 2006). This concept was expanded to 
create a micro-spherical heart pump by surrounding a hollow sphere containing inlet and 
outlet ports with a cardiomyocyte cell sheet. As the cells contracted around the elastic 
sphere, capillary fluid motion in the cell culture medium became oscillatory with a heart-
like pumping motion that did not require a wired or electrical connection (Tanaka et al., 
2007b). Feinberg and colleagues altered the shape and thickness PDMS-based thin films 
to create machines that displayed pumping characteristics (Figure 2.1A). A coiled-spring 
actuator oscillated between systolic (rolled) and diastolic (loosely coiled) states in 
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response to the cyclic contraction of the cardiomyocytes. Another structure resembling a 
helical paper towel tube was capable of extension and rotation, prompting the authors to 
propose a “simple suction mode micro-pump.” Finally, an arched thin film was seeded 
with cardiomyocytes on its concave surface to form a gripping device (Feinberg et al., 
2007). Nawroth, Feinberg, Parker and colleagues also demonstrated the successful 
reverse engineering of a jellyfish-like structure (termed a “medusoid”, Figure 2.1D) that 
acted as a muscle-based pump. A jellyfish proved to be an ideal model for such a 
demonstration, as only a few cell types, including muscle cells and motor neurons, are 
necessary for actuation (Nawroth et al., 2012).  
2.1.3 MUSCLE-BASED BIOLOGICAL ACTUATORS 
The advantages of using muscle cells (cardiac or skeletal) for biological machines 
are numerous. First, unlike traditional machines that require an external energy source, 
these cells can be powered with glucose and other ions or biomolecules. Additionally, 
muscle cells instinctively respond to mechanical forces and displacements of their 
environments. The ability to sense and quickly adapt to cues and applied stimuli is both a 
characteristic of muscular tissues and a requirement for higher-order biological machines. 
Cardiomyocytes in particular are able to self-synchronize through electrical 
communication (Pilarek et al., 2011). Muscle performs almost silently, and the waste 
produced from the conversion of biochemical fuel to mechanical waste is biodegradable 
(Dennis & Herr, 2005). Finally, a muscle cell can produce a higher force of contraction 
than another type of cell or micro-organism. As a motor, muscle can efficiently produce a 
workload of 1000 Joules for every 1 gram of consumed glucose (Herr & Dennis, 2004). 
Many other synthetic actuating devices are unable to perform similarly and cannot 
achieve the same range of sizes and forms that muscle tissue can.   
Some engineered actuators naturally evolved from constrained structures to 
freestanding devices capable of net displacement. Xi and colleagues integrated a silicon-
based microelectromechanical system (MEMS) cantilever device with a sacrificial 
thermally responsive polymer, poly-N-isopropylacrylamide (PNIPAAm), over which 
cardiac cells were seeded. By allowing the cells to adhere to specified locations and 
create anisotropic patterns guided by the chemistry of the surface, they permitted the 
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components to ‘self-assemble’ into a functional system. A system with cantilevers of 
different lengths was used to analyze the mechanical properties of muscle cells as their 
contraction (power stroke) displaced the cantilevers in a repeated manner. Mobile and 
autonomous devices were also released, using the MEMS-based thin film structure as a 
backbone that the muscle bundle could bend to produce forward movement (Figure 
2.1C). The maximum observed velocity was 236 μm/s with an average frequency of 1.8 
Hz (Xi et al., 2005). 
Feinberg et al. created centimeter-scale, cardiomyocyte-based “biohybrid 
muscular thin films” that were engineered to perform various tasks (swimming and 
walking) based on a micro-base that was able to spontaneously achieve a specific shape. 
The machines harnessed energy from a combination of the unique structure-function 
relationship of the PDMS material and its geometric and mechanical properties. When 
the various 2D PDMS films were released from a PIPAAm-coated glass cover slip, they 
accepted different 3D conformations that varied depending on PDMS thickness, stiffness, 
and temperature. The degree of isotropy of the 2D myocardium dictated contractility, and 
observed specific forces were comparable to those of native cardiac tissue. The walking 
“myopod” maintained a velocity of 133 μm/s with electrical stimulation, while the 
triangular swimmer moved with an average speed of 30 μm/s (Feinberg et al., 2007).   
Perhaps the most efficient pathway to creating a functional bio-actuator has been 
to mimic nature’s own work. Kim and colleagues designed a “crab-like micro-robot” 
consisting of three PDMS legs connected to a central body, upon which cardiomyocytes 
adhered and contracted to produce net displacement over a ten-day period (Figure 2.1B). 
The grooved, fibronectin-coated backbone allowed for greater mechanical output of the 
cardiac cells. Asymmetry from the variance of leg lengths provided the key geometric 
factor for net motion with an observed average velocity of 100 µm/s (Kim et al., 2007). 
Although the fabrication technology allowed for mass production of devices, molding is a 
time consuming process that is limited in terms of materials.  
A more recent biological actuator from Chan and colleagues produced net motion 
but was manufactured with a simpler, faster, and more flexible fabrication system. 
Building on previous work demonstrating the use of 3D stereolithography to create a 
multi-material cantilever of poly(ethylene glycol) diacrylate (PEGDA) and acrylic-PEG-
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collagen, the researchers created a millimeter-scale “bio-bot” that not only mimicked the 
native myocardium in terms of elasticity, but also was able to move upon a surface in 
fluid (Figure 2.1E). A sheet of cardiomyocytes seeded on top of the bimorph cantilever 
contracted to induce a power stroke that moved the bio-bot forward with an average 
beating frequency of 1.5 Hz and a maximum velocity of 236 µm/s, resulting in a net 
displacement of approximately one body length in 30 seconds (Chan et al., 2012).  
In addition to devices with the ability to “walk” or “crawl”, various machines 
have been designed to move through a body of fluid without surface contact by 
mimicking water-based organisms. Herr and Dennis created a swimming biological robot 
with frog semitendinosus muscles that was able to start, stop, turn, and swim in a straight 
line at over 1/3 body lengths per second. However, this “bio-mechanotronic” design was 
integrated with an embedded micro-controller, and could not swim without this 
stimulation (Herr & Dennis, 2004). As described earlier, Nawroth’s medusoids 
(millimeter-scale muscle-elastomer bilayers) were composed of rat cardiomyocytes and a 
thin layer of PDMS in an open-bell shape with eight radiating lobes. When electrical field 
stimulation was applied to the fluid, the medusoids responded in a way that mimicked the 
swimming and feeding mechanisms of the real organism, achieving velocities of 0.4-0.7 
body lengths per stroke (Nawroth et al., 2012). 
 
 
Figure 2.1: Engineered Biological Actuators. (A) A coiled muscular thin film (Feinberg et al., 2007) (B) 
Biohybrid crab-like micro-robots (J. Kim et al., 2007) (C) A self-assembled micro-device driven by muscle 
power (Xi et al., 2005) (D) Medusoid actuator resembling a jellyfish (Nawroth et al., 2012) (E) “Walking” 
cantilever bio-bot (Chan et al., 2012) 
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2.2  STEREOLITHOGRAPHY  
2.2.1 FUNDAMENTALS OF STEREOLITHOGRAPHY 
Stereolithography is a liquid-based rapid prototyping technology that uses a light 
source to build a computer-designed part in an additive, layer-by-layer fashion. It was the 
first solid freeform fabrication technique to be commercially available in the mid-1980s 
(Melchels et al., 2010). Since then, it has been used for a wide range of applications on 
different size scales.  
The basic operation of a stereolithography apparatus (SLA) involves five steps: 
creation of a computer-aided design (CAD) model (or equivalent design), conversion into 
a tessellated (.stl) file, slicing into parallel horizontal layers, preparation of 
polymerization specifications (layer thickness, building style, cure depth, and hatch 
spacing), and finally, building. During this last step, a laser beam is focused at the surface 
of the material and controlled by a computer to directly trace a pattern onto the surface of 
a resin, a liquid material that has the ability to solidify rapidly upon exposure to light. The 
energy of the photon must be greater or equal to the energy difference between the 
ground and excited states for the resin material. When the material absorbs adequate 
energy, reactive species are produced and chemical cross-linking occurs via an 
exothermic process (Bártolo, 2011; Jacobs, 1992). After the resin is polymerized to a 
certain depth, the platform is lowered a specified distance, the object is re-coated with 
resin (either manually if the resin is held in a container on the platform, or automatically 
by lowering the platform into a vat of liquid resin), and the laser polymerizes the second 
layer, continuing in this manner until all layers are completed (Figure 2.2). Adherence to 
the previous layer is ensured by the fact that the laser penetrates deeper than the specific 
layer thickness to cure some unpolymerized groups from the first layer (Cho & Kang, 
2012; Melchels et al., 2010). 
The laser is a continuous beam of solid, liquid, or gaseous form that is sent 
through a beam-expanding telescope and series of scanning mirrors. In a gas laser, the 
laser head contains a discharge tube that determines the laser’s performance 
characteristics by providing an optical gain, the heat exchanger dissipates wasted heat 
generated in the laser tube, and the power supply excites and regulates the electrical 
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current. In a helium cadmium (HeCd) laser (which uses a wavelength of 325 nm and 
power around 40 mW), neutral helium atoms are excited to a metastable state and can 
then collide with neutral cadmium atoms, causing an excitation state from which both 
visible and ultraviolet (UV) light propagates (Jacobs, 1992). The smallest possible feature 
is dictated by the laser beam diameter, which is typically 250 μm but can be as low as 75 
μm in high-resolution systems. Because the laser scans the surface of the resin, the 
horizontal precision is about equal to half of the width of the beam. Maximum power 
density is achieved at the focal point of the lens (i.e., the location of minimum beam 
diameter) (Arcaute et al., 2011; Bártolo, 2011; Bertsch & Renaud, 2011).  
 
 
Figure 2.2: Stereolithography Flow Process.  Adapted from (Melchels et al., 2010)  
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Polymerization is achieved through the use of a photoinitiator (PI) in the pre-
polymer solution that reacts with photons from the UV light to produce free radicals.  
These catalytic radical species propagate through the material to chemically link 
monomer units into larger polymer chains in a process that includes initiation, 
propagation, and termination. The time of polymerization is dependent on the 
responsiveness and the surface tension of the photopolymer, speed of the scanning 
mirrors, and power and wavelength of the laser (Jacobs, 1992).  
A “Working Curve” equation is derived from the Beer-Lambert Law, which 
describes the intensity of light’s exponential decay as it travels through an absorbing 
medium. The equation quantifies the relationship between the maximum exposure 
(𝐸!"#), the critical energy dose needed to polymerize the material from a liquid to a solid 
gel state (𝐸!), the thickness or cure depth (𝐶!), and the penetration depth (𝐷!) of the laser 
into the material: 𝐶! = 𝐷! ∙ ln 𝐸!"!𝐸!  
The critical energy dose needed to solidify the resin depends on the photoinitiator 
concentration and amount of dissolved oxygen as well as other inhibiting species in the 
local environment. The equation is valid within a cure depth range of 𝐷! < 𝐶! < 4𝐷! 
(Jacobs, 1992). This Working Curve relationship between energy and thickness (for 
different materials) can be used to create design parameters for fabricated structures. 
The application dictates the material choice. Tissue engineering scaffolds should 
eventually be able to degrade, whereas materials for bone defects, dental implants, 
vascular stents, and other medical applications should maintain mechanical and structural 
integrity over time. Depending on the material, when the fabricated object is placed in a 
solvent, swelling can occur. Distortion of the structure can result, demonstrating the 
importance of material choice (Cho & Kang, 2012). Certain polymer units, such as vinyl 
acrylate monomers with a carboxylic (-COOH) group and carbon-carbon double bonds, 
are more reactive than others. Chemical modification of the material before 
polymerization can result in different post-fabrication material properties (Jacobs, 1992). 
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2.2.2 BIOMEDICAL APPLICATIONS OF STEREOLITHOGRAPHY 
Over the past few decades, stereolithography has been used increasingly for 
biomedical applications. For example, Gibson et al. detailed the use of rapid prototyping 
technology for medical models: image data obtained from a patient’s CT, MRI, or 
ultrasound scans can be converted to an appropriate format using medical software and 
then used to aid the surgeon in diagnosis, pre-operative planning, and models of body 
parts or implants based on the exact specifications of the patient’s needs (Gibson et al., 
2006). Other uses of stereolithography for medical purposes have included oral and 
maxillofacial surgery, where the natural bone or tissue is modeled and reconstructed for 
cosmetic and functional applications; artificial joints (knees, hips, and articular joints); 
nerve guidance channels; surgical tools for complex surgeries; printing of avascular 
organs (such as ears and aortas); and customized implants such as hearing aids (Boland et 
al., 2007; Melchels et al., 2010). However, because the smallest feature size is regulated 
by the specifications of the system and spot size of the laser, the minimum resolution is a 
limiting factor for accuracy in medical applications (Gibson et al., 2006; Peltola et al., 
2008). 
2.2.2.1 STEREOLITHOGRAPHY FOR TISSUE ENGINEERING 
Tissue engineering is the creation of functional organs and tissues for the repair or 
replacement of injured or diseased body parts (Peltola et al., 2008). It combines a 
biocompatible material with cells, biomolecules, and growth factors in a supportive 
scaffold, matrix, or gel system. Most tissue-engineered systems must be able to support 
cell proliferation and migration in a spatially distributed manner. The 3D micro-
environment offers mechanical support, a nutrient supply, and cell adhesion to mimic the 
native extracellular matrix (ECM). Complex pore geometry is difficult to achieve with 
conventional assembly methods; for this reason, stereolithography can be used to rapidly 
fabricate a scaffold or system with controllable geometric and mechanical properties on 
both the micro- and macro- scales. It has the advantage of being able to polymerize a 
range of biomaterials with varying degrees of degradability (Cho & Kang, 2012).    
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2.2.2.2 CELL ENCAPSULATION AND ALIGNMENT WITH POLYMERIZED HYDROGELS 
Hydrogels are a widely used biomaterial because of their mechanical resemblance 
to native ECM tissue and ability to be chemically and biologically modified for use with 
cells and proteins. Dhariwala and colleagues were the first to demonstrate successful 
encapsulation of cells using SLA technology. They polymerized 3D rings of 
poly(ethylene oxide) (PEO) and poly(ethylene glycol) dimethacrylate (PEGDMA) 
hydrogels with Chinese hamster ovary (CHO-B2) cells.  Cytotoxicity was evaluated as a 
function of PI concentration, with an average of 64% live cells after 3 days in culture 
(Dhariwala et al., 2004).  Others soon established encapsulation methods for other cell 
types such as fibroblasts and marrow stromal cells, with many cells exhibiting better 
post-fabrication viability with the incorporation of RGD (Arg-Gly-Asp) peptides (Lu et 
al., 2006; Melchels et al., 2010). 
Arcaute, Mann, and Wicker first used stereolithography to polymerize 
photoreactive PEGDMA (MW 1000) structures with encapsulated cells. A study of the 
polymerized cure depths based on pre-polymer concentrations and applied energy dose 
was used to find the optimal conditions for long-term encapsulation within the 
centimeter-scale gel disks. They demonstrated 87% viability of dermal fibroblasts after 
24 hours, with no significant decrease during the two hours following fabrication. 
Additionally, they demonstrated that increasing the concentration of PI also increased 
cytotoxicity – a concern when working with living cells. A PI concentration less than 
0.5% was recommended for long-term studies (Arcaute et al., 2006, 2011). These results 
were used to create multi-material, PEG-based scaffolds with polymerized bio-active 
domains for specific cell adhesion, as cells will not attach to inert PEG hydrogels 
(Arcaute et al., 2010).   
Chan et al. encapsulated NIH/3T3 fibroblasts in polymerized PEGDA hydrogels 
of different molecular weights (MW 700, 3400, and 5000, representing a range of 
physiologically relevant stiffness values from 5-500 kPa). Higher molecular weights 
increased the swelling ratio (and pore size) of the hydrogel, but decreased the elastic 
modulus. The highest relative cell viability after 14 days (quantified by MTS assay) was 
observed with PEG MW 3400 chemically linked with RGDS peptides. Cells were also 
labeled with different fluorescent dyes to demonstrate multi-layer patterning capabilities 
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of the SLA (Chan et al., 2010). This study was extended to include the encapsulation 
C2C12 muscle cells, PC12 neuron-like cells, primary hippocampal neurons, and adipose-
derived stem cells in various PEG-based materials. The study allowed for the 
examination of cellular interactions as well as the influence of spatial organization and 
regulation defined by the SLA (Bajaj et al., 2012; Zorlutuna et al., 2011). 
Jeong, Chan, and colleagues encapsulated NIH/3T3 fibroblasts into a fabricated 
“microvascular stamp” made of permeable PEGDA-MA (methacrylic alginate) hydrogels. 
The cells were induced to secrete pro-angiogenic growth factors that localized within the 
cylindrical channels of the circular stamp. When the stamp was implanted on an 
embryonic chick chorioallantoic membrane (CAM), neovessels sprouted and formed in 
the pattern of pre-defined features. The SLA easily produced stamps with different 
pattern geometries; a channel diameter of 500 μm resulted in the greatest quantity of 
functional neovessels in vivo (Jeong et al., 2012). This group also demonstrated the use of 
the SLA in combination with micro-contact printing (μCP) to pattern cell alignment on 
3D hydrogels with ECM proteins. They used a polydimethylsiloxane (PDMS) stamp to 
apply acryl-fibronectin protein “ink” to a glass coverslip, on top of which a PEGDA 
hydrogel was polymerized. The construct was inverted and seeded with NIH/3T3 cells 
that adhered to the protein domains. The width of the patterned acryl-fibronectin lines 
was altered in order to maximally align the cells (Chan et al., 2012). 
2.2.3 OTHER RAPID PROTOTYPING TECHNOLOGIES 
Other rapid prototyping technologies allowing for layer-by-layer fabrication can 
be liquid-based (two-photon polymerization), solid-based (fused deposition modeling), or 
powder-based (selective laser sintering and 3D printing). These methods are favored 
because of their relative speed when compared to other traditional fabrication techniques 
such as molding or casting (Melchels et al., 2010). However, in comparison to other rapid 
prototyping techniques, the relative ease of iterations, enhanced visualization capabilities, 
lower cost and cycle time, short time frame from idea conception to physical part, and 
ability to cure a wide range of materials and photopolymers make stereolithography a 
more attractive technology with a myriad of biomedical applications.  
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2.3  FIBRIN AS A BIOMATERIAL  
2.3.1 FIBRIN STRUCTURE, POLYMERIZATION, AND MECHANICAL PROPERTIES 
Fibrin is a hydrogel with a 3D branching fiber network. The fibrin monomer is 
made from the cleavage of fibrinogen, a 45 nm long glycoprotein comprised of 
polypeptide chains, by the enzyme thrombin. Thrombin is a proteolytic enzyme that 
selectively cleaves fibrinopeptides at the Arg-Gly residues in the central region on the 
fibrinogen molecule, and is activated by the cleavage of prothrombin in response to 
injury or foreign surfaces (Weisel, 2005). In vitro, a specific quantity or concentration of 
thrombin is added to fibrinogen, which initiates the fibrin clotting process; in vivo, the 
process is dynamic and the thrombin concentration changes during the course of the 
reaction, depending on local conditions (Wolberg, 2007). 
 The removal of the fibrinopeptides (which prevent spontaneous polymerization) 
exposes specific binding sites that result in half-staggered arrangement and lateral 
aggregation of fibrin protofibrils. The fibrin monomers that result can combine into 
staggered two-stranded protofibrils, which aggregate laterally to form twisted fibers 
(Figure 2.3). When energy of bonding is exceeded by the energy required to stretch an 
additional protofibril, lateral growth of the fiber terminates. As protofibrils diverge, fibers 
can be branched into a 3D network, with the majority of branches consisting of an 
intersection of three fibers. Branching is essential for fibrin to become a space-filling 
hydrogel material. The material is soluble as a fibrinogen monomer but insoluble as a 
fibrin gel. Factor XIIIa is a transglutaminase (activated by thrombin) that stabilizes the 
clot from mechanical, chemical, and proteolytic harm. It forms a covalent bond between 
the lysine resides from one fibrin molecule and the glutamine resides in another molecule 
(Ryan et al., 1999; Weisel, 2005, 2007). In general, fibrin polymerizes relatively quickly 
when compared to other ECM proteins such as collagen and laminin, an intuitive feature 
considering the prominent role that fibrin plays in blood clotting and wound repair in vivo 
(Janmey et al., 2009).  
Mechanically, fibrin filaments are relatively ‘soft’ compared to other filamentous 
biomaterials. The elastic modulus of a fibrin strand has been measured to within 1.5-10 
MPa, which is less than that of actin and microtubules (Collet et al., 2005). The 
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individual fibers comprise a low volume fraction of the polymer and can undergo large 
deformations without breaking; it has been shown that fibers can strain up to 120% 
without any evident damage from the extension (Liu et al., 2006).  
Fibrin is a viscoelastic material, displaying properties of an elastic solid, in which 
deformation is proportional to applied stress and independent of strain rate, as well as a 
viscous liquid, where stress is proportional to strain rate but independent of deformation 
itself (Weisel, 2007). Its viscoelastic mechanical properties are closely linked to function; 
in vivo, a fibrin blood clot must be able to respond to and withstand blood flow pressure 
and have the strength to stop blood flow (Weisel, 2004). Its mechanical properties, which 
are those of native connective tissue, make fibrin a useful scaffold material for the 
engineering of cartilage, nerve tissue, and cardiovascular tissue; however, it does not 
exhibit sufficient mechanical strength for bone repair applications (Janmey et al., 2009).   
 
 
Figure 2.3: Polymerization and degradation of fibrin. Fibrinogen is cleaved by thrombin to produce a 
fibrin monomer, which polymerizes to form protofibrils. Plasmin (which forms when plasminogen is 
activated) can degrade fibrin unless inhibited by a fibrinolytic inhibitor.  
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2.3.2  FIBRINOLYSIS AND ANTI-FIBRINOLYTIC AGENTS 
The process of coagulation and clotting (fibrin polymerization) is actively and 
equally opposed in a physiological equilibrium by fibrinolysis, a system that removes 
fibrin residues that could otherwise permanently occlude the vascular system. Despite 
cross-linking by Factor XIIIa during polymerization, fibrinogen is extremely susceptible 
to degradation by proteases. Plasminogen is activated as plasmin by an activator such as 
tissue-type plasminogen activator (tPA); plasmin then cleaves fibrin at specific sites 
(Figure 2.3).  Fibrin can act as both a substrate and a cofactor for plasmin; molecules can 
promote the generation of plasmins that degrade the clot, which can be useful for 
renewing the blood supply to cells at the clot site (Weisel, 2007; Wolberg, 2007). Natural 
inhibitors of plasmin and plasminogen activators (tissue activator, urokinase, or 
streptokinase) are present in the circulatory system to prevent indiscriminate fibrinogen 
digestion. Plasmin is a protease secreted by many different cells to rapidly degrade fibrin 
after the affected area is restored to its original structural integrity. The entire process is 
regulated by positive and negative feedback loops; unchecked fibrinolysis can result in 
hemorrhage (Kupcsik et al., 2009; Prentice, 1980).   
Degradation by plasmin and resulting fibrin instability is a drawback to tissue 
engineering with fibrin, and a plasmin inhibitor must be incorporated for systems lasting 
longer than a few hours. ε-Aminocaproic acid (ACA) and aprotinin are anti-fibrinolytic 
agents that inhibit the degradation of fibrin by serine proteases such as plasmin, thus 
maintaining structural integrity. ACA binds to the lysine binding sites present on both 
plasmin and plasminogen, preventing plasmin from being activated and binding to (and 
subsequently degrading) fibrin by competitive and stoichiometric inhibition. Kupcsik et 
al. studied the use of ACA on chondrogenic differentiation of human mesenchymal stem 
cells (hMSCs) and its general use in cartilage engineering constructs. They found that it 
did not significantly affect gene expression patterns or glycosaminoglycan (GAG) 
production, thereby proving its long-term usefulness in tissue engineered systems 
(Kupcsik et al., 2009; Valentovic, 2007). Huang et al. compared the effects of ACA and 
aprotinin on rat bone marrow mesenchymal stem cell (BM-MSC) chondrogenesis in 
fibrin constructs. BM-MSCs are naturally recruited to repair articular cartilage defects as 
a result of blood flow disruption when a clot forms. The two proteins have different 
 17 
mechanisms of plasmin inhibition, but no significant difference in their effects on DNA 
content was observed (Huang et al., 2007). However, in comparison to ACA, aprotinin 
can be expensive to isolate and is a less specific inhibitor of plasmin (Kupcsik et al., 
2009).   
 
2.3.3 USE OF FIBRIN IN TISSUE ENGINEERING AND DRUG DELIVERY 
Fibrin is an attractive biomaterial because, unlike synthetic hydrogels, it naturally 
displays two RGD sites that allow it to bind cell integrins, vascular endothelial cadherins, 
growth factors, and other proteins (fibronectin, hyaluronic acid, and albumin) (Bach et al., 
1998; Janmey et al., 2009; Weisel, 2005). Its high water content and biodegradability also 
greatly support cell processes, and it displays a similar structure in vitro and in vivo (Kidd 
et al., 2012). The abundance and ease of purification of fibrinogen from a patient’s own 
bloodstream also make it an appealing biomaterial for in vivo and clinical studies by 
eliminating the possibility of an immune response (Lei et al., 2009). Additionally, 
gelation time of fibrin can be meticulously controlled by altering the concentrations of 
fibrinogen and especially thrombin (Janmey et al., 2009).  Pore size, degree of branching, 
and fiber thickness can be dictated by the polymerization conditions (including 
parameters such as pH, and concentration of plasma proteins), and cell migration and 
differentiation within the matrix can be made more efficient by controlling its mechanical 
and biochemical properties (Weisel, 2007). Because of its wide range of capabilities, 
fibrin has been used in almost every tissue engineering application over the past decade 
and a half, from wound repair to drug delivery, cell differentiation, and therapeutic 
scaffolds for cardiovascular repair, regenerative medicine, and angiogenesis. 
Kidd et al. used fibrin hydrogels with hydroxyapatite (HA) particles as carriers 
for lentiviral gene delivery, easily tailoring the release profile by altering the interaction 
of the scaffold and the drug or growth factor (Kidd et al., 2012). Alternatively, fibrin can 
be injected in vivo to form a gel and be naturally degraded as a biopolymer.  Lei et al. 
used fibrin as a gene delivery system by embedding DNA in the gel prior to 
polymerization. The gel system permitted spatial distribution of transfection while 
minimizing toxicity. Fibrinolytic inhibitors actually slowed the degradation process and 
resulted in decreased transfection efficiency, demonstrating the application-specific need 
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for fibrin scaffold degradation (Lei et al., 2009). Fibrin gels have also been utilized as a 
scaffold to deliver MSCs to a wound site, promoting bone formation and healing in 
degradable delivery mechanism. The use and delivery of MSCs is promising for 
therapeutic applications, as the stem cells have the capacity to differentiate into 
chondrocytes, adipocytes, myoblasts, and osteoblasts (Bensaıd̈ et al., 2003).  
Fibrinogen’s human origin renders it an attractive biomaterial and a potentially 
autologous transplant device. The benefits of fibrin in clinical tissue engineering have 
recently been demonstrated by the development of a bioengineered ocular surface, an 
“injectable” liver to transferred immobilized hepatocytes, millimeter-scale vascular grafts 
seeded with arterial-derived cells, and engineered aortic heart valves made from dermal 
fibroblasts within molded gels (Bruns et al., 2005; Han et al., 2002; Koch et al., 2010; 
Robinson et al., 2008).  
 
2.3.4 USE OF FIBRIN IN MUSCLE ENGINEERING AND REGENERATION 
The interactions of human myocytes and fibrin matrix in a physiologically 
relevant 3D culture model were characterized extensively by Chiron et al. in 2012. The 
morphology of embedded myoblasts changed from a round shape upon polymerization to 
an elongated formation oriented along the gel axis on the first day, which was attributed 
to the cells re-orienting themselves in relation to the tension provided by the silicone 
structures. α5 integrin and vinculin were more highly expressed in 3D than 2D cultures, 
and actin stress fibers had a prevalent orientation along the direction of the gel alignment 
and cell orientation. Whereas fused myotubes can be branched and randomly aligned in 
2D, the cells observed in 3D culture were aligned along the gel axis. The elastic modulus 
of the gels increased with cell differentiation over time, demonstrating the implications of 
microenvironment and substrate elasticity on cell organization and fate. The increase in 
stiffness (which was measured to be similar to the value of native skeletal tissue) with 
differentiation also implied the important role of cell contractility (Chiron et al., 2012).  
Previously, Engler et al. had shown that the formation of sarcomeres in cultured 
myocytes was dependent on the stiffness of the substrate being nearly equal to that of 
physiological muscle (Engler et al., 2004). 
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Many groups have successfully employed fibrin for muscle tissue engineering and 
regeneration. Beier et al. mixed fibrin gel with myoblasts to create a novel injectable cell-
matrix solution to fill a muscle fiber defect (Beier et al., 2006). A bioengineered cardiac 
heart muscle developed by Hecker and colleagues used primary cardiomyocytes and a 
fibrin support matrix within a micro-perfusion system that regulated pH, temperature, and 
rate of media flow in a physiological environment to encourage tissue viability (Hecker et 
al., 2008). More recently, Gerard et al. examined the use of fibrin gels to encapsulate and 
transplant myoblasts as a regenerative therapy for dystrophin restoration in Duchenne 
Muscular Dystrophy. Gel degradability and cell proliferation were measured for different 
fibrinogen concentrations, with a lower concentration (3 mg/ml) proving the most 
effective for increasing cell survival, metabolic activity, and dystrophin expression 
(Gerard et al., 2012).    
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2.4  SKELETAL MUSCLE ENGINEERING 
 
2.4.1 SKELETAL MUSCLE PHYSIOLOGY AND DEVELOPMENT 
Skeletal muscle is the only type of voluntary muscle in the human body. It 
connects to the skeleton via tendons and supports movement, locomotion, respiration, and 
other activities (Watras, 2008). The formation of skeletal muscle in embryogenesis 
begins with progenitor cells in the vertebrate limb.  Extensive proliferation of progenitor 
cells is followed by the expression of deterministic myogenic factors and finally 
differentiation into skeletal muscle (Figure 2.4A) (Buckingham et al., 2003). In adult 
tissue, satellite cells are present in a quiescent state under the basal lamina along the 
myofibers (Li et al., 2011). Injury to adult muscle or other stimulation results in 
activation of these progenitor cells and subsequent division and differentiation into new 
myofibers (Gerard et al., 2012).   
During myogenesis, the fusion of myoblast precursor cells produces multi-
nucleated myotubes with one cytoplasm. Commitment to a myogenic lineage involves 
withdrawal from the cell cycle and the expression of genes that are specific to muscle 
(Duan et al., 2010).  Muscle growth begins with primary fibers, which eventually become 
slow-twitch fibers; when the primary fibers become innervated, secondary fibers (fast-
twitch) form around them (Ontell & Kozeka, 1984). Three layers of connective tissue 
(endomysium surrounding individual fibers; perimysium, encompassing the fascicles; 
and epimysium surrounding the entire muscle) surround skeletal muscle in vivo as a 
barrier from physical stress and damage (Khodabukus & Baar, 2009; Watras, 2008).   
Adult skeletal muscle is longitudinally aligned and multi-nucleated in a modular 
hierarchy, beginning with single fibrils that group together to form fibers and fascicles 
(Figure 2.4B) (Li et al., 2011; Watras, 2008). Over this wide range of length scales, 
however, the relationship between structure and function is maintained. This range also 
accounts for the span of observed forces, frequencies, and dimensions of skeletal muscle. 
Contraction can reach a frequency upwards of 100 Hz, with forces reaching over a kilo-
Newton, and the length of skeletal muscle extending over 1 meter in some organisms 
(Feinberg et al., 2007). 
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Figure 2.4: Skeletal Muscle. (A) Myogenesis: activation, proliferation, and differentiation (Zammit et al., 
2006) (B) Skeletal muscle hierarchy and dimensions (Lieber, 2002)  (C) Intracellular signaling cascade of 
IGF-I resulting in protein synthesis or degradation (D) Organization within a myofibril (Marieb, 2006)   
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The organization of actin and myosin within skeletal muscle sarcomeres produces 
a striated structure in the myofibrils (Figure 2.4D). The sarcoplasmic reticulum 
surrounds individual myofibers and controls the concentration of calcium ions (a key 
regulator of contraction and force production) within the cell. An action potential 
traveling along the sarcolemma reaches a T-tubule (an invagination of the sarcolemma), 
resulting in a release of Ca2+ ions from the sarcoplasmic reticulum. After the intracellular 
concentration of Ca2+ increases, the ion binds to troponin C, resulting in a shift of the 
tropomyosin molecule away from the myosin binding site on actin. Actin-myosin binding 
initiates sarcomere shortening and contraction of the muscle (Watras, 2008). 
The basement membrane of skeletal muscle is referred to as the basal lamina and 
its formation is initiated by fibroblasts. The role of the basal lamina in providing the 
necessary elasticity and strength for muscle is of critical importance. It also provides key 
binding sites for the sequestration of myogenic growth factors for muscle development 
and helps to maintain neuromuscular junctions (NMJs). Collagen IV, laminin-2, and 
proteoglycans are present in abundance in skeletal basal lamina. Fibroblasts also play a 
role in myofiber maturation and support.  
 
2.4.2 NEED AND OVERVIEW 
The engineering of functional skeletal muscle is imperative for regeneration and 
replacement of pathologically damaged or injured native tissue. These defects and 
myopathies are somewhat ‘doomed’ by the limited self-regeneration of skeletal muscle 
and therapeutic strategies that cannot overcome limited survival of transplanted cells and 
donor site morbidity. 
Extracellular matrix proteins such as collagen I and fibrin are natural hydrogels 
that allow for muscle cell proliferation and spreading, alignment of cells in a common 
direction, and tissue contraction on a macroscopic scale. As such, they have been used in 
abundance as supportive proteins for skeletal muscle engineering, and have been more 
successful than delivering precursor cells to an injury site. An organized ECM surrounds 
native skeletal tissue in the basal lamina. As is the case with many diverse cell types, the 
ECM also contributes to the maintenance of cellular processes and communication in 
normal growth and development of skeletal cells (Bian & Bursac, 2008; Hinds et al., 
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2011). However, the volume fraction of extracellular material is small compared to that 
of the fibers in muscle tissue, and an engineered muscle construct with excess ECM 
material could hinder myotube formation and constrain specific force (Huang et al., 
2005). 
 
2.4.3 ENGINEERED MUSCLE CONSTRUCTS 
A novel technique to rapidly form engineered skeletal muscle constructs with 
ECM proteins was developed by Huang et al. in 2005. The researchers used fibrin gel to 
create three-dimensional tubules of primary myoblasts and matrix protein that contracted 
around a pair of sutures 12 mm apart on a PDMS-coated dish. The decision to use fibrin 
protein was multifold: it allowed for cell migration and proliferation, was degraded after 
a few weeks as cells produced their own matrix proteins, and could bind to some 
myogenic growth factors. A force transducer was attached to one end of the muscle 
cylinder and electrical stimulation was applied. The tissue constructs contracted 
maximally with a tetanic force greater than 800 μN after three weeks in culture, and 
addition of 25 ng IGF before seeding resulted in a significantly increased force output. 
The force-frequency and length-time relationships were reported on the same scale as 
those of native skeletal tissue (Huang et al., 2005). 
Bian, Bursac, and colleagues first developed an array of staggered micro-molded 
hexagonal PDMS posts around which skeletal tissue and hydrogel networks could form 
in a spatially controlled manner. The placement of the posts allowed for “microfabricated 
tissue pores” that guided the alignment and organization of dense myofibers and endorsed 
diffusion of nutrients and oxygen to the cells. The ability to change the position and 
architecture of the posts allowed for various degrees of muscle tissue arrangement, 
morphology, and complexity (Bian & Bursac, 2009; Bian et al., 2009).  This technology 
was improved when Bian and Bursac studied the effect of pore length and geometry on 
the morphology, alignment, myogenesis, and contraction of engineered muscle. Pore 
elongation increased cell alignment and total contractile force without compromising 
individual myofiber force capability. The resulting widening of the pores (i.e., narrowing 
of tissue bundles) also increased the porosity of the tissue, demonstrating global changes 
on functional output from local changes in tissue architecture (Bian et al., 2012). 
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A study by Khodabukus and Baar examined the use of fibrin as a matrix system 
for engineered skeletal muscle tissue in place of collagen, which they hypothesized 
would allow for more accurate functional testing, as fibrin has mechanical properties and 
stiffness similar to native muscle tissue. Because two-dimensional structures cannot 
provide accurate measurements of muscle cell force, especially since stiff culture surfaces 
limit myogenesis in favor of osteogenesis, three-dimensional constructs with fibrin 
matrix were used to engineer muscle using C2C12 cells and NIH/3T3 fibroblasts. 
Electrical force stimulation was applied via electrodes on either side of the muscle 
constructs. The constructs with aprotinin formed more quickly and produced a higher 
specific force over time. The researchers found that maximal force production was 
significantly affected by C2C12 clonal variations as well as variations in the serum batch 
and the serum content in the media. The addition of fibroblasts eliminated the force 
deficit (decrease in twitch force after stimulation), but also decreased the specific force of 
the constructs. Output forces ranged between 100-200 µN and were not significantly 
altered after repeated testing for weeks. They also proved that high serum media resulted 
in faster differentiation and increased force (Khodabukus & Baar, 2009).   
Hinds and colleagues recently studied the effect of ECM composition and density 
on the formation and functional contractile force output of engineered skeletal muscle 
constructs similar to those used by Huang et al. Fibrin, collagen I, and Matrigel of 
varying concentrations were combined with primary skeletal muscle myoblasts in a gel 
solution and allowed to form muscle bundles in silicone molds. Spontaneous contractions 
were evident after about a week of culture, and continued to be observed for the duration 
of the study at a frequency of less than 3Hz. The bundles were removed after two weeks 
and analyzed in terms of active and passive tension.  The choice of ECM protein did not 
affect cell organization or spontaneous contractions in the muscle bundles, but different 
matrix proteins demonstrated various degrees of compaction, with collagen based fibers 
exhibiting the highest passive tension and stiffness, as well as compaction (in contrast to 
the findings of Bian and Bursac), but greatest degree of rupture. Higher concentrations of 
both fibrin and Matrigel reduced bundle compaction and average myotube diameter while 
increasing time to tetanus. In total, the researchers found that the bundles made of fibrin 
demonstrated a higher degree of mechanical integrity and generated contractile forces 
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that were measured to be three times greater than those made of collagen I. The most 
optimal conditions (producing the highest force of contraction and largest myotube 
diameters) came from the gels made of 4 mg/mL fibrinogen and 40% Matrigel, 
demonstrating the impact of matrix composition on functional output (Hinds et al., 2011). 
Li et al. created muscle from primary mouse myoblasts (PMMs) and mouse 
embryonic fibroblasts (MEFs) from pregnant mice in various ratios to study the role of 
fibroblasts in skeletal muscle self-assembly.  The cells were allowed to self-assemble into 
muscle constructs on 3D laminin and fibrin gels. Alignment in 3D resulted from the 
tensile forces from the spontaneous contraction of the muscle strip, as well as the tension 
generated by the fibrin gel. After 10 days in differentiation media, a physiological 
fascicle-like structure had formed with aligned cells. Staining confirmed that the structure 
contained ~500 nuclei through the diameter and that the myofibers were mature 
(multinucleated with sarcomeric striations). The muscle constructs formed in 3D were 
significantly longer than those formed in the 2D culture. When the PMMs were co-
cultured with MEFs in an optimal 1:1 ratio, the viability, size, and number of myotubes 
increased significantly, most likely due to the role that fibroblasts play in the secretion of 
growth factors during myogenesis. It was also hypothesized that the MEFs played a role 
in degradation of the fibrin scaffold and decreasing the stiffness of the construct, thereby 
producing a sufficient force of contraction to roll up the cell sheet (Li et al., 2011).  
Nagamine and colleagues devised a method to micropattern C2C12 myotubes in a 
flexible fibrin-PDMS sheet for a practical cell-based bioassay technology. Following 
differentiation in culture on a line-patterned polymer, cells were transferred onto the 
sheets after the fibrin solution was added over the cells.  Another layer of fibrin was 
added onto the other side of the sheet to encapsulate the cell patterns within the gel, and 
concentrated electrical stimulation was applied using a conducting polymer-coated 
microelectrode arrays.  The presence of the polymer allowed for long-term stimulation in 
a minimally invasive and harmful manner.  Each microelectrode could be controlled to 
induce independent contraction of the cell pattern lines.  The system was used as a 
functional metabolic bioassay to monitor translocation of a glucose transporter within the 
myotubes upon contraction (Nagamine et al., 2011). 
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A “skeletal muscle on a chip” was created by Sakar et al. using a C2C12 
myoblast-Matrigel-collagen I matrix suspension that was allowed to compact 
longitudinally around cantilevers in a PDMS microwell.  The myoblasts were transfected 
with a plasmid to express channelrhodopsin-2 (ChR2), an optogenetic ion channel that 
causes contraction upon exposure to blue light (see Section 5.1). The ability to illuminate 
(stimulate) individual myofibers permitted localized and selective contraction and 
movement of the pillars with multiple degrees of freedom. The cantilevers provided 
simultaneous reporting of the force generation (10.8 ± 0.18 μN static tension with an 
active force of 1.41 ± 0.25 μN generated from contraction) while acting as functional 
artificial tendons to anchor the muscle tissues. The researchers argued that the factors that 
define skeletal from cardiac muscle (namely, length and structure) allow for greater force 
production and regulation (Sakar et al., 2012).  
 
2.4.4 INSULIN-LIKE GROWTH FACTOR-I AND MYOGENESIS 
Insulin-like growth factors (IGFs, so-called because of their evolutionary 
conserved structures that are similar to insulin) are part of a family of proteins that play a 
role in skeletal tissue growth in many vertebrate species through autocrine and paracrine 
mechanisms. Binding of the IGF ligand to a cell membrane IGF-receptor triggers an 
intracellular signaling cascade that terminates with regulation of genes and transcription 
factors in the nucleus. Specifically, insulin-like growth factor I (IGF-I) encourages 
myoblast proliferation and differentiation as well as myofiber hypertrophy (Duan et al., 
2010; Shansky et al., 2006). However, while the effects cascade from the same IGF 
receptor, these processes are independently regulated on different temporal scales. 
Proliferation results from myogenic inhibition and is exclusive of myogenic 
differentiation events (Florini et al., 1991).  
The IGF-I pathway is highly conserved and affects skeletal muscle growth 
through protein synthesis and degradation (Figure 2.4C). After IGF-I binds to a cell-
surface receptor, intracellular kinase is activated, resulting in subsequent and sequential 
phosphorylation of insulin receptor substrate (IRS), phosphatidylinositol-3-kinase (PI3K), 
phosphoinositide-3,4,5-triphosphate (PIP3), and finally Akt. The Akt kinase is a key 
player in the cascade and regulates mammalian protein synthesis through targeting of 
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rapamycin (mTOR) kinase, as well as protein degradation through the FoxO family of 
transcription factors, which are responsible for expression of ligases that ubiquitinate 
myosin muscle proteins (Manning & Cantley, 2007). Additionally, IGF-I or –II receptor 
binding can also activate the p38 MAPK pathway to promote differentiation (Duan et al., 
2010).  Many feedback loops are used to regulate these pathways within the cell. 
Salmon and Daughaday were the first to validate that growth hormones could 
release growth factors such as IGF into the bloodstream from the liver, while Hill and 
colleagues proved that cultured myoblasts could also release IGFs. Since then, many 
knockout studies have validated the important role of IGF in skeletal muscle development 
by examining each component of the IGF pathway (Florini et al., 1996; Hill et al., 1984; 
Salmon & Daughaday, 1957).  
In contrast, many groups have studied the effect of IGF addition on growth and 
hypertrophy. Over-expression of IGF-I has been recognized to increase muscle fiber size 
and strength while decelerating muscle decline in differentiated myofibers (Barton et al., 
2002; Barton-Davis et al., 1998). Vandenburgh and colleagues demonstrated the use of 
IGF-I to quickly increase the diameter (hypertrophy) of skeletal muscle myofibers 
embedded in collagen. After 5 days in culture they observed a 79% increase in myofiber 
diameter and 87% more nuclei, a direct result of the role of IGF-I in stimulating protein 
synthesis and inhibiting protein degradation (Vandenburgh et al., 1991). Shansky et al. 
engineered constructs of C2C12 skeletal muscle cells that secreted IGF-I and monitored 
the effect on co-cultured avian skeletal muscle in a perfused bio-chamber. After 11 days, 
levels of IGF-I in the avian muscle chamber increased linearly, and cells in that chamber 
displayed significantly larger myofibers (and in greater quantity) than the non-secreting 
C2C12 control. This proved that secretion of IGF-I from transduced myoblasts was 
adequate to produce a direct paracrine effect on non-transduced myoblasts (Shansky et al., 
2006). Finally, differentiation of myoblasts into myotubes (highly regulated by MyoD, 
Myf5, myogenin, and various transcription factors) has been shown to accelerate with the 
addition or over-expression of IGFs (Buckingham et al., 2003; Ren et al., 2008; Stewart 
et al., 1996).   
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3. METHODOLOGY 
3.1 DESIGN AND FABRICATION  
3.1.1 MATERIALS 
The pre-polymer solution for the bio-bot consisted of 20% (v/v) poly(ethylene 
glycol) diacrylate of MW 700 g/mol (PEGDA MW 700, Sigma-Aldrich) dissolved in 
phosphate buffered saline (PBS, Lonza), with 0.5% (v/v) 1-propanone, 2-hydroxy-1-[4-
(2-hydroxyethoxy)phenyl]2-methyl- photoinitiator (Irgacure 2959, BASF) mixed from a 
50% (v/v) stock solution in dimethyl sulfoxide (DMSO, Fisher Scientific) (Figure 3.1A). 
The pre-polymer solution for the polymerized holder was made from 20% (w/v) 
poly(ethylene glycol) dimethacrylate of MW 1000 g/mol (PEGDMA MW 1000, 
Polysciences, Inc.), dissolved in PBS, and mixed with 0.5% (v/v) Irgacure 2959 diluted 
from a 50% (v/v) stock solution in DMSO. 
 
3.1.2 PREPARATION AND FABRICATION 
A Stereolithography Apparatus (SLA) was used to selectively polymerize the 
material by tracing a pattern on the surface of the pre-polymer liquid with a 325nm HeCd 
gas laser. After polymerizing the first layer, the stage moves down a distance that is equal 
to the height of the first layer, the surface is re-coated with another layer of pre-polymer 
solution, the laser beam is re-focused, and the second layer is polymerized. The additive 
process continues in this “bottom-up” fabrication method until the entire part is built. 
A commercial SLA System (250/50, 3D Systems, Table 3.1) was modified for 
polymerization as previous described (Chan et al., 2010). Briefly, the parts were designed 
in AutoCAD (2013, Autodesk) and then exported to 3D Lightyear software (1.4, 3D 
Systems), which was used to slice the part into 2D layers for the SLA. To build the bio-
bots, a 35mm petri dish (BD Falcon) was treated with an O2 plasma treatment system to 
render the surface hydrophilic. An 18x18 mm square No. 1 micro cover glass (VWR) was 
secured to the center of the dish using double-sided tape. The dish was placed in the 
center of the stage and an initial volume of 1200 μl of PEGDA MW 700 pre-polymer 
solution was added with a pipette for polymerization of the bio-bot beam.  𝐷! was altered 
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to change the polymerization energy of the beam. 250 μl of pre-polymer solution was 
added manually for each subsequent polymerized layer, which became the bio-bot pillars 
(Figure 3.1B).  The polymerization energy was not altered for the pillars. 
To build the holder for the bio-bot, a 35 mm dish was similarly treated with an O2 
plasma treatment system. The cover glass slides were methacrylated by treatment with 
0.2% (v/v) 3-(trimethoxysilyl)propyl methacrylate (3-TPM, Sigma-Aldrich) in 200 proof 
ethanol (100% EtOH, Decon Labs, Inc.) on a shaker for 5 minutes. The 3-TPM solution 
was removed and the slides were washed in 100% EtOH on a shaker. After 3 minutes, the 
slides were removed and allowed to dry face-up on a hot plate at 110ºC for 10 minutes.  
Finally, each slide was taped face-up in a 35 mm dish and polymerization occurred as 
described above.   
Laser Type Gas (HeCd) 
Wavelength 325 nm 
Max Power 40 mW 
XY Resolution 250 μm 
Z Resolution 50 μm 
Table 3.1: SLA 250/50 system specifications  
3.1.3 POST-PROCESSING OF FABRICATED PARTS 
Immediately following fabrication, each bio-bot or holder structure was placed in 
a dish and immersed in PBS on a shaker for 5-10 minutes to be rinsed of excess pre-
polymer solution.  The fabricated structures were sterilized in 70% ethanol for 1 hour and 
transferred to a dish containing PBS to re-swell for at least 1 hour.  Structures were stored 
in PBS at 4ºC until use (Figure 3.1C). Before cell seeding, each fabricated bio-bot 
structure was positioned upside down in a holder, which was placed in a 35 mm cell 
culture dish (Corning, Inc.).  Excess liquid was aspirated using a glass Pasteur pipette. 
3.2 CELL CULTURE  
3.2.1 GROWTH CONDITIONS 
C2C12 murine myoblasts were transfected with pAAV-Cag-Chr2-GFP-2A-Puro 
plasmid to express ChR2 as described in (Sakar et al., 2012).  Cells were a gift from Prof. 
Harry Asada at MIT.  
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The ChR2 C2C12 cells were maintained in growth medium (GM) in a cell culture 
incubator at 37ºC and 5% CO2. GM consisted of Dulbecco’s Modification of Eagle 
Medium with L-glutamine and sodium pyruvate (DMEM 1X, Corning Cellgro), 
supplemented with 10% fetal bovine serum (FBS, Lonza), 1% penicillin-streptomycin 
and 1% L-glutamine (Cellgro Mediatech, Inc.). 
 
3.2.2 DIFFERENTIATION 
Differentiation medium (DM) consisted of DMEM with 2% or 10% horse serum 
(HS, Lonza) and supplemented with 1% penicillin-streptomycin and 1% L-glutamine.  
Human insulin-like growth factor-I (IGF-I, Sigma-Aldrich) and anti-fibrinolytic 6-
aminocaproic acid (ACA, Sigma-Aldrich) were added as described in Table 3.2.  
Name Serum IGF-I (ng/ml) ACA (mg/ml) 
GM 10% FBS 0 0 
DM(2%HS) 2% HS 0 0 
DM(2%HS+IGF) 2% HS 50 0 
DM(10%HS) 10% HS 0 0 
DM(10%HS+IGF) 10% HS 50 0 
DM(10%HS+ACA) 10% HS 0 1 
DM(10%HS+ACA+IGF) 10% HS 50 1 
Table 3.2: Differentiation medium components 
3.3 FORMATION OF CELL-MATRIX MUSCLE STRIP 
 
3.3.1 CELL SEEDING AND MATRIX COMPONENTS 
An ice-cold cell-matrix solution of Matrigel basement membrane matrix (30% of 
total cell-matrix volume, BD Biosciences), fibrinogen (4 mg/ml, Sigma-Aldrich), 
thrombin from bovine plasma (0.5 U/mg fibrinogen, Sigma-Aldrich), and ChR2 C2C12s 
suspended in cold GM at a concentration of 5x106 cells/ml were added to each holder in a 
total volume of 90 μl (hour 0) (Figure 3.1D). At hour 1, 4 ml of GM was added to each 
35 mm dish. At hour 24, the bio-bots were released from the holders and the appropriate 
DM was added to induce differentiation of the myoblasts into myotubes (Figure 3.1E). 
The media was changed every 24 hours thereafter and the bio-bots were transferred to 
new 35 mm tissue culture dishes as necessary. The bio-bots were maintained in a cell 
culture incubator at 37ºC and 5% CO2. 
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Figure 3.1: Fabrication And Cell Seeding Process. (A) AutoCAD software is used to design the bio-bot 
with the desired dimensions. A pre-polymer solution consists of poly(ethylene) glycol diacrylate (PEGDA) 
MW 700 and a photoinitiator, Irgacure 2959. (B) A modified commercial stereolithography apparatus (SLA) 
is used to polymerize the parts in an additive process with a 325 nm HeCd gas laser. (C) The polymerized 
parts: i, bio-bot; ii, holder. (D) The cell-matrix solution consists of C2C12 skeletal muscle myoblasts, 
fibrinogen, thrombin, and Matrigel. (E) Side-view images of the addition of cell-matrix solution into the 
holder containing the bio-bot (i-ii). The cells and matrix contract around the pillars to form a muscle strip 
and the device is released from the holder (iii). Scale bar, 1 mm.   
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3.3.2 COMPACTION AREA 
To measure the cross-sectional compaction area, the holders containing the bio-
bots seeded with the cell-matrix suspension were imaged at 0.8X zoom using a 
stereomicroscope (MZ FL III, Leica Microsystems) with a digital microscope camera 
(Flex, SPOT Imaging Solutions) at hours 1, 6, 9, 12, and 24.  The Measure tool in ImageJ 
software (National Institutes of Health, NIH) was used to calculate the cross-sectional 
area by quantifying the visible compacted area of the cell-matrix solution and subtracting 
the cross-sectional area of the pillars.   
 
3.4 MATERIAL CHARACTERIZATION 
 
3.4.1 WORKING CURVE  
Cylinders with a radius of 1 cm and a height of 100 μm were fabricated from 
PEGDA MW 700 with 0.2 μm Nile Red fluorescent microbeads (Spherotech) 
encapsulated in a 1:500 ratio of beads to polymer.  𝐸!"# was varied from 71 to 512 
mJ/cm2 by maintaining a constant 𝐸!  value and changing the input 𝐷!  value. The 
thicknesses of the fabricated parts (𝐶!) were measured using an inverted fluorescent 
microscope (IX81, Olympus) with a TRITC excitation filter. The beads encapsulated in 
the bottom-most plane of the cylinder were brought into focus and this location was set as 
zero. The focus was then set on the top-most plane of encapsulated beads in the cylinder 
and this change in displacement was recorded as the height of the cylinder. Four parts 
were fabricated for each energy dose and an average height was taken from four points 
per part. The average thickness was plotted against the applied energy dose and a 
logarithmic trendline was fit to the data to create a Working Curve.  
3.4.2 MECHANICAL TESTING AND DETERMINATION OF ELASTIC MODULUS 
To characterize the mechanical properties of the material (PEGDA MW 700), 
dogbone-shaped test specimens were fabricated with the same thickness as that of the 
bio-bot beam and with energy doses ranging from 95 to 513 mJ/cm2.  Each specimen was 
fixed in a hydrated sample chamber using custom-fabricated structures and an 
ElectroForce® BioDynamic® test instrument (5100, Bose) with a 1000 g load cell was 
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used to apply tension at each end. A video extensometer was used to track the 
displacement of a fixed point on the sample until fracture. The cross-sectional area of the 
sample was measured three times using calipers and averaged. The stress was then 
computed using the applied tensile load 𝐹 divided by the cross-sectional area 𝐴. The 
elastic modulus 𝐸 was determined from the linear portion of the stress-strain curve for 
each material, according to Hooke’s Law, assuming a slow strain rate:  𝜎 = 𝐹𝐴 = 𝜀 ∙ 𝐸 
The elastic modulus was plotted as a function of the applied energy dose and a 
logarithmic trendline was fit to the results. 
3.5 BENDING AND PASSIVE TENSION 
 
3.5.1 PASSIVE TENSION 
Devices were fabricated with a range of energy doses from 95 to 513 mJ/cm2 for 
the bio-bot beam. The stiffness of the pillars was kept constant. Cell-matrix solution was 
added as described above.  Side-view images of the bio-bots were taken every 24 hours 
after seeding using a stereo-microscope at 0.8X zoom with a digital microscope camera.  
The passive tension in the muscle strip (i.e., tension at rest) was determined using 
an Euler-Bernoulli linear beam theory. The differential equation given below relates the 
deflection of a curved beam to an applied moment: −𝑃𝑙𝐸𝐼 =  𝑑𝜃𝑑𝑠 =   𝑦′′1− 𝑦!" 
where 𝑃 is the tension in the muscle strip, 𝑙 is the moment arm from the muscle strip to 
the beam, 𝐸 is the elastic modulus of the beam, 𝐼 is the moment of inertia of the beam, 
and 𝑦 is the deflection of the beam from the horizontal (Figure 3.2). With the assumption 
that the rotation in the beam (𝑦′) approaches zero, the right side of the equation is 
approximated as 𝑦′′, the curvature.  Equating the applied moment 𝑀 to the tension 𝑃 
times the moment arm 𝑙, the equation becomes: 𝑑!𝑦𝑑𝑥! =  𝑀𝐸𝐼 
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For a rectangular cross-section, the moment of inertia is determined using the 
measured dimensions (width, 𝑏, and height, ℎ) of the beam: 𝐼 = 𝑏ℎ!12  
 Boundary condition (BCs) were applied by assuming zero deflection at the ends 
of the beam (𝐿 = 0) and maximum deflection at the center !! . Then, the second-order 
differential equation was solved for 𝑦: 𝑦 =  𝑀𝑦!2𝐸𝐼 −  𝑀𝐿𝑦2𝐸𝐼  
 The maximum deflection (𝛿!"#, measured using ImageJ) at the center of the 
beam was calculated using the previous equation: 𝛿!"# =   𝑦 𝐿2  =  𝑀𝐿!8𝐸𝐼  
This equation was rearranged to solve for the moment, 𝑀. Again, this quantity is 
also a product of the passive tension force 𝑃 in the muscle strip and the moment arm 𝑙: 𝑀 =  8𝐸𝐼𝛿!"#𝐿! = 𝑃𝑙 
The dimensions of the beam and moment arm were found using the Measure Tool in 
ImageJ. Three measurements were taken for each dimension of each device and averaged. 
Solving the equation for 𝑃 yields a measure of the passive tension in the muscle 
strip as a function of material and geometric properties as well as the maximum 
deflection of the beam: 𝑃 =  8𝐸𝐼𝛿!!"𝑙 𝐿!   
 
Figure 3.2: Schematic Showing Beam In Compression With Applied Moment.  𝛿!"# is the maximum 
deflection of the beam and 𝒍 is the moment arm from the muscle strip to the beam. 
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3.5.2 ANSYS SIMULATION AND MODELING 
To model the bio-bot, the design was reconstructed using SolidWorks software. 
The assembly was then imported into ANSYS for finite element analysis. The 
appropriate material properties and calculated passive tension were assigned and a force 
was applied to the base at a distance specified by the moment arm (measured in ImageJ). 
The resultant solution of total deformation was examined to find the maximum deflection 
of the beam, and this result was compared to the original measurement to determine the 
error of the simulation. 
3.6 IMMUNOFLUORESCENCE  
3.6.1 IGF-ANALYSIS IN CULTURE 
An in vitro study was performed to quantify the effects of IGF-I on ChR2 C2C12 
myoblasts. Cells were seeded at a density of 1x105 myoblasts per well in a 12-well plate 
with GM. When cells achieved 90% confluency (day 0), the media was changed to 
DM(2%HS) or DM(2%HS + IGF).  After days 0, 3, 7, 10, 14, and 17, cells were fixed in 
4% formaldehyde (from 36% stock solution, EMD Chemicals) and permeabilized with 
0.1% Triton X-100 (Sigma-Aldrich) in PBS (PBST) for 10 minutes. A 1% (w/v) blocking 
solution of albumin from bovine serum (BSA, Sigma-Aldrich) was added for 35 minutes.  
The cells were then incubated with anti-sarcomeric alpha actinin primary antibody (α-
actinin, 1:200, Abcam) with 1% BSA in PBST for 1 hour. Goat anti-Rabbit IgG H&L 
TRITC-conjugated secondary antibody (1:200 in 1% BSA in PBST, Abcam) was added 
for one hour in the dark. DAPI nuclear stain (Invitrogen) at a 1:50000 dilution in 
sterilized DI water was added for 5 minutes in the dark. All steps were carried out at 
room temperature. Cells were immediately imaged using an inverted fluorescent 
microscope.  Using ImageJ software, red and blue pseudo-color were added to the images 
for α-actinin and DAPI, respectively, and the number of multi-nucleated myotubes was 
quantified by counting the cells for each condition and time point and averaging across 
samples.  Results from Day 0 are not shown, as no myotubes were visible.     
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3.6.2 STAINING AND CONFOCAL IMAGING OF MUSCLE STRIPS 
The bio-bot muscle strip was isolated from the device by cutting the pillars and 
gently removing the muscle strip with tweezers. The tissue was then fixed in 4% 
paraformaldehyde (from 16% stock solution, Electron Microscopy Sciences) for 30 
minutes, washed in PBS, and then permeabilized with 0.2% Triton X-100 for 5 minutes.  
Image-iT® FX Signal Enhancer (Invitrogen) was added for 30 minutes.  The tissue was 
then incubated with primary antibodies with Image-iT® FX diluted 1:100 in PBS.  MF-
20 anti-myosin heavy chain (1:100, Developmental Studies Hybridoma Bank (DSHB)) 
was added for 2 hours. Alexa Fluor® 488 goat anti-mouse IgG secondary antibody 
(1:200, Invitrogen) was added, and incubation in Image-iT® FX diluted in PBS was 
carried out for 2 hours in the dark. DAPI nuclear stain was added for 10 minutes in the 
dark at a 1:5000 dilution in sterilized DI water. The muscle strips were then fixed to a 35 
mm glass-bottom microwell dish (MatTek) with 1% agarose gel and imaged with a 
confocal microscope (LSM 710, Zeiss). Image stacks were acquired and processed using 
Zen software (2010, Zeiss) and ImageJ.  
3.7 ANALYSIS OF ACTUATION  
The spontaneous contraction and locomotion of the bio-bots was measured using 
a camcorder (Handycam DCR-SR65, Sony) on a custom-built stage or an inverted 
microscope (IX81, Olympus). Displacement was calculated in ImageJ by manually 
overlaying subsequent frames and measuring the distance traveled during each time point. 
Frequency was measured by counting the number of contractions in each time segment. 
3.8 STATISTICAL ANALYSIS 
Results are presented as mean ± standard deviation (SD). Statistical analyses were 
performed with OriginPro software and represent one-way ANOVA and Tukey’s Test.   
* represents a significance level of p < 0.05 and ** represents p < 0.01. 
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4. RESULTS AND DISCUSSION 
4.1 DESIGN AND FABRICATION  
4.1.1 WORKING CURVE 
The average energy from the SLA is determined by re-arranging the Working 
Curve Equation (see Section 2.2.1, Figure 4.1A): 𝐶! = 𝐷! ∙ ln 𝐸!"#𝐸!  𝐸!"# = e !! !! ∙ 𝐸!  
The user can specify the polymerization energy of the 250/50 SLA by changing the 𝐷! 
and 𝐸!  values. When the thickness of the material is plotted against the exposure on a 
logarithmic scale, the result is a straight line with a slope equal to 𝐷! (Jacobs, 1992).  
 Increasing the molecular weight of the pre-polymer (from 20% PEGDA MW 700 
to 20% PEGDMA MW 1000) increased the slope of the Working Curve. Additionally, 
increasing the PI concentration of Irgacure I2959 from 0.5% to 1% in the PEDGA MW 
700 pre-polymer solution decreased the slope, i.e. the dependence on changes in 
polymerization energy (Figure 4.1B). Fitted trendlines produced values of R2 > 0.979 for 
all materials. These findings are consistent with the results presented by Arcaute et al.; in 
characterizing the fabrication of PEG-based constructs, it was shown that an increase in 
PI concentration resulted in thinner gels (Arcaute et al., 2006).  
Characterization of the system with variable parameters such as pre-polymer 
concentration, molecular weight, and PI concentration provided a reference for future 
designs. A desired layer thickness could be achieved simply by specifying 𝐷! and 𝐸! .   
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Figure 4.1: Working Curve. (A) The laser penetrates a depth DP into the material to ensure adherence to 
the previous layer. The relationship between CD, DP, and energy dose is given by the Working Curve 
equation. (B) The Working Curve was plotted to determine thickness as a function of energy dose for 3 
different materials. Increasing the molecular weight and decreasing the PI concentration increased the slope.  
4.1.2 MECHANICAL TESTING AND ELASTIC MODULUS 
Our group previously observed that changing the polymerization energy from the 
SLA produced a varying elastic modulus (a measure of stiffness in elastic materials) of a 
PEGDA hydrogel (Chan et al., 2012). This property was used to “forward engineer” the 
bio-bot, once again demonstrating the flexibility of design and customization made 
possible by simply changing input parameters of the SLA.  
Because the SLA allows a part to be built in multiple steps, layers can be 
produced with different materials or properties. We varied the 𝐷! and 𝐸!  values to obtain 
bio-bots with beams of varying stiffness values. All other parameters (material, PI 
concentration, and pillar stiffness) were kept constant so that only the effect of energy 
dose on stiffness could be determined. Increasing the energy dose of polymerization 
logarithmically increased the stiffness (modulus) of the beam material (R2 > 0.99, Figure 
4.2). These values were used to calculate other quantities of the system, such as passive 
tension. Characterization of the material properties also provided a basis for future 
designs that could easily be altered to achieve a specific bending or movement profile.  
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Figure 4.2: Material Properties of the Bio-Bot Beam. The elastic modulus of the beam was calculated as 
a function of energy dose from a tensile stress-strain curve. Increasing the energy dose of polymerization 
resulted in a higher modulus. In collaboration with Mike Poellman.  
4.2 COMPACTION OF MUSCLE STRIP  
4.2.1 CROSS-SECTIONAL AREA 
An analysis of the top-view images of the cell-matrix solution condensing around 
the pillars suggested that the cross-sectional area began to stabilize (i.e., the rate of 
compaction slowed) around hour 24 (Figure 4.3). Although compaction continued to 
occur until hour 48, the bio-bots were released at hour 24, which proved to quicken the 
remaining compaction around the pillars (data not shown). We hypothesize that the 
compaction of the cell-matrix solution around the pillars is due to two factors: first, as the 
cells settle within the matrix, they begin to exert traction forces on the fibrous proteins 
via integrin attachments; second, polymerization of the fibrin monomers results in a 
cross-linked polymer gel structure. A greater degree of compaction could indicate a 
physiological arrangement more similar to native skeletal tissue.  
4.2.2 COMPACTION WITH IGF-I 
An analysis of the top-view images of the cell-matrix solution compacting around 
the pillars proved that the addition of IGF-I to DM at hour 24 accelerated the rate of 
compaction (Figure 4.4). The cross-sectional area (shown normalized to the area at hour 
24 for each condition) decreased more quickly in the day after IGF-I was added (i.e., at 
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hour 48) compared to the controls without IGF-I. The bio-bots with DM(10%HS + IGF) 
and DM(10%HS + ACA + IGF) demonstrated a decreased cross-sectional area (26.26% 
decrease, p = 0.12; and 11.75% decrease, p = 0.16, respectively) compared to the control 
of DM(10% HS) or DM(10%HS + ACA). Because IGF-I is known to increase the rate of 
myogenesis (see Section 2.4.4 and Figure 4.5), it is probable that the fused myotubes 
exerted greater traction forces on the matrix in order to increase compaction. 
 
Figure 4.3: Compaction of Cell-Matrix Solution. (A) During the 24 hours after seeding, the cells and 
fibrin/Matrigel matrix condensed around the pillars to form a solid muscle strip (top view). (B) The cross-
sectional area of the muscle strip decreased over the first 24 hours due to compaction; n = 20. 
 
 
Figure 4.4: Effect of DM Components on Compaction. Addition of IGF-I increased the degree of 
compaction (i.e., decreased the cross-sectional area more quickly) from hour 24-48.  
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4.3 DIFFERENTIATION MEDIA COMPONENTS  
4.3.1 EFFECT ON MYOTUBE FORMATION 
Before adding IGF-I to the DM for the bio-bots, we studied its effect on myoblast 
differentiation in culture. Although the culture conditions between 2D and 3D culture 
differ greatly (flat, stiff, tissue culture plastic versus a compliant matrix with room for 
migration and proliferation), the study provided a basic understanding of how IGF-I 
would affect the C2C12s, both spatially and temporally. 50 ng/ml IGF-I was added to the 
dish when myoblasts neared 100% confluency (day 0) and the effect was observed until 
day 17. For every time point after day 0, the number of myotubes in the samples with 
IGF-I was significantly increased (p < 0.05 or p < 0.01) compared to the control (no IGF-
I) (Figure 4.5). The decrease between day 3 and day 7 can be attributed to additional 
fusion of cells, which thereby decreased the total number of myotubes. We also 
hypothesized that the rate of fusion would increase further with a higher concentration of 
horse serum; therefore, all future experiments were conducted with 10% HS.  
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Figure 4.5: Effect Of IGF-I On Myotube Formation. (A) Fluorescent images demonstrating the 
differentiation and maturation of myotubes in DM(2%HS+IGF) versus DM(2%HS). Scale bar, 100 μm. (B) 
The number of myotubes was significantly increased for each time point with the addition of IGF-I 
compared to the control. Values are presented as mean ± SD. Statistics represent one-way ANOVA and 
Tukey’s test, with (*) = p < 0.05 and (**) = p < 0.01 for n = 2-3.     
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4.3.2 EFFECT ON LIFETIME OF MUSCLE STRIPS 
The effect of varying concentrations of HS, IGF-I, and ACA in DM on the 
lifetime of the bio-bots was studied by monitoring the number of days until the muscle 
strip ruptured (Figure 4.6). No significant difference was observed between DM(2%HS) 
and DM(10%HS) (8.5 and 8.75 days, respectively). A significant increase (from 8.75 to 
25 days, a 185% increase, p < 0.01) was observed with the addition of the anti-
fibrinolytic agent ACA compared to the DM(10%HS) control. C2C12s can produce 
plasminogen, which activates plasmin to degrade fibrin; therefore, an anti-fibrinolytic 
agent was necessary to delay rupture of the muscle strip (Khodabukus & Baar, 2009). 
The addition of 50 ng/ml IGF-I decreased the number of days until failure (4.25 
days), potentially due to the increased tension within the muscle strip resulting from a 
greater number of mature myotubes (Figure 4.5). Again, adding IGF-I to the media 
slightly decreased the lifetime compared to DM(10%HS + ACA), but not significantly 
(from 25 to 19.5 days, a 22% decrease), indicating a more substantial dependence of the 
muscle strips on degradation than myotube formation. Due to these results, the bio-bots 
were supplemented with DM(10% HS + ACA + IGF) unless otherwise specified. 
 
Figure 4.6: Effect of DM Components on Lifetime of Muscle Strips. (A) Boxplot representation of the 
effect of 50 ng/ml IGF-I, 1 mg/ml aminocaproic acid (ACA), and concentration of horse serum (HS) in 
differentiation media on the lifetime of the muscle strips (i.e., days until mechanical failure of cell-matrix). 
Boxes represent 25th, 50th, and 75th percentile; (•) represents mean value; whiskers represent ± SD. 
Statistical significance represents one-way ANOVA and Tukey’s test, with (**) = p < 0.01 compared to 
control (10% HS) for n = 4.  (B) The broken muscle strips.  Scale bar, 1 mm.  
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4.4 BENDING AND PASSIVE TENSION  
4.4.1 BENDING 
As discussed, the energy dose of polymerization from the SLA could be altered to 
achieve different mechanical properties of the material. The energy dose was varied from 
95 to 513 mJ/cm2 to achieve bio-bots with five distinct bending profiles (Figure 4.7). The 
lowest energy dose resulted in a beam with a lower elastic modulus. This increase in 
compliance in the less stiff hydrogels provided less resistance to bending; thus a higher 
deflection in the beam was observed. Conversely, the highest energy dose (513 mJ/cm2) 
produced a beam with the highest modulus, and the resulting stiffness created a resistance 
that the cells could not overcome to move the pillars. Therefore, the bending in the stiffer 
beam was negligible in comparison.   
 
Figure 4.7: Bending with Time and Energy Dose. The polymerization energy from the SLA dictated the 
mechanical properties of the material. Over time, bio-bots polymerized with different energy doses exhibit 
different bending profiles in the beam. 
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4.4.2 PASSIVE TENSION 
The passive tension in the muscle strip was analyzed using material properties 
(elastic modulus of the beam) as well as geometric properties and maximum deflection of 
the beam from the horizontal (found using an analysis of images shown in Figure 4.7).  
Using the linear bending theory discussed in Section 3.5.1, the tension was calculated 
every 24 hours until the muscle strips broke. Calculation of the tension proved 
quantitatively what had been observed qualitatively: increasing the energy dose of 
polymerization resulted in an increased stiffness in the beam that increased the tension in 
the muscle strip. For energy doses of 95, 109, 138, and 266 mJ/cm2, the passive tension 
values were approximately 800, 975, 1035, and 1275 μN, respectively. After stabilizing 
(i.e., after the first 2-4 days after seeding, during which the compaction and bending 
continued to increase), the tension remained fairly consistent throughout the lifetime of 
the muscle strips, with a standard deviation between approximately 4-16 μN depending 
on the energy dose. The tension (as well as energy dose and elastic modulus) was 
inversely related to the lifetime of the muscle strips (indicated by an × in Figure 4.8). 
The resistance to bending increased the tension in the matrix of the muscle strip, which 
could not be sustained long-term. It has been demonstrated that skeletal muscle force 
output increases under mechanical stimulation and stretching, which explains the increase 
in passive tension with stiffness (Bach et al., 2004). During myogenesis, mechanical 
stimulation affects protein expression, gene regulation, and metabolic activity; passive 
and active forces are both influential in muscle maturation (Goldspink et al., 1992; 
Powell et al., 2002). Another result of the increased stiffness could be a further degree of 
alignment within the muscle strip, which is closer to the native organization of functional 
skeletal muscle, and could also increase the tension (Koning et al., 2009).  
Bio-bots incubated in DM without IGF-I, i.e. DM(10%HS + ACA) were 
compared in order to quantify the effect of IGF-I on the passive tension in the muscle 
strips. The addition of IGF-I increased the passive tension for the 109 mJ/cm2 bio-bot 
from 839.83 ± 11.61 to 962.18 ± 5.16 μN (14.59%) during the observed period when the 
muscle strips were intact (days 3-16, Figure 4.9A). Similarly, the tension in the 138 
mJ/cm2 bio-bot increased from 935.05 ± 6.56 to 1040.87 ± 2.86 μN (11.32%) during the 
same time period. Consistent with the decreased lifetime observed in bio-bots with the 
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addition of IGF-I (see Figure 4.6A above), these bio-bots cultured with IGF-I did not last 
as long before the muscle strip broke as compared to those without IGF-I (Figure 4.9B). 
These results suggest that the increase in tension with IGF-I (due to an increased number 
of mature myotubes that are about to displace the pillars with a greater force) adversely 
affected the lifetime of the muscle strips by creating a tension that could not be sustained.  
  
Figure 4.8: Passive Tension. Passive tension in the muscle strip as a function of time and energy dose for 
n = 2. Increasing the stiffness of the beam resulted in a higher tension and faster time to break (×). In 
collaboration with Ritu Raman. 
 
Figure 4.9: Effect of IGF on Passive Tension. (A) Addition of IGF-I to the culture medium increased the 
average passive tension in the muscle strips between 11-15% compared to the control (no IGF-I). (B) The 
tension in the muscle strips remained fairly consistent through day 16, but eventually those with IGF-I 
broke sooner due to the increased tension that could not be sustained. In collaboration with Ritu Raman. 
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4.4.3 ANSYS MODELING AND ERROR 
An ANSYS simulation was used to model the global displacement of the beam 
and pillars using finite element analysis (Figure 4.10). Modeling of the design provided 
another method to “forward engineer” the bio-bot by using known quantities (material 
properties, elastic modulus, and passive tension) to simulate changes in design 
parameters and view the resulting bending profile. The resultant global deformation at 
192 hours was compared to the original measurement of the deflection of the beam.  
 
 
Figure 4.10: Modeling. ANSYS simulation demonstrating global change in displacement of the bio-bot 
beam and pillars at 192 hours. Scale bar, 1 mm.  In collaboration with Ritu Raman. 
 
 
 
Figure 4.11: Simulation Error. The measured and simulated values of maximum displacement recorded 
for bio-bots of various energy doses at 192 hours are compared. The values of percent error between the 
actual and simulated displacements are between 13-14%. In collaboration with Ritu Raman. 
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It was found that the simulation approximated the actual displacement with 
absolute values of the errors ranging from 13-14%, depending on the energy dose 
(Figure 4.11). As part of an imperfect biological system, this error can be accounted for 
by several variables, including nonlinear effects (large deformation and rotations), a non-
uniform distribution of cells and matrix within the muscle strip, slight non-uniformity and 
asymmetry in the actual device, and the cases where the bottom caps of the pillars are 
touching in some bio-bots.  
4.5 MATURITY AND FUNCTIONALITY 
In order to determine the degree of maturation, alignment, and distribution of the 
skeletal muscle cells within the muscle strip, the muscle strips were fixed, stained, and 
imaged with a confocal microscope. Fluorescent markers stained for MF-20, a mature 
sarcomeric myosin protein, as well as DAPI for the nuclei. Fluorescent analysis also 
allowed for the examination of the effects of IGF-I on differentiation and maturity. 
Figure 4.12 shows the distribution of cells within the matrix with the addition of 
IGF-I. It is clear from the fluorescence intensity that there are greater numbers of cells 
around the periphery, most likely due to the limited diffusion of nutrients and oxygen to 
the cells in the middle of the muscle strip. The alignment of some cells around the border 
could be attributed to the tension in this direction. Myotubes can be identified by their 
length (in contrast to rounder myoblast) and multiple nuclei.  
Figure 4.13 depicts the arrangement of muscle cells within a muscle strip without 
IGF-I. Although multinucleated myotubes are visible (see Figure 4.13 inset), there are 
fewer throughout the matrix than in the muscle strips with IGF-I, confirming the role of 
IGF-I in increasing the rate of myogenesis. Figure 4.13D demonstrates the presence of 
myotubes along with many myoblasts. The density of myotubes is not as great as those 
seen with IGF-I in Figure 4.12C-D. Further fluorescent imaging at different time points 
could confirm this hypothesis with a quantitative analysis of maturation and cell number. 
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Figure 4.12: Confocal Imaging with IGF-I. (A) DAPI nuclear stain of region of muscle strip. (B) MF-20 
myosin sarcomere stain of same region of muscle strip. (C) The density and alignment of myotubes are 
visible along the edge of the muscle strip. (D) Myotubes within the muscle strip.  Scale bar, 100 µm (all).  
 
Figure 4.13: Confocal Imaging without IGF-I. (A) DAPI nuclear stain of entire muscle strip. (B) MF-20 
myosin sarcomere stain of entire muscle strip. Scale bar, 500 µm (A,B). (C) Merged image; inset, myotube 
along muscle strip perimeter. (D) Detail of cell organization and maturity. Scale bar, 100 µm (C,D). 
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4.6 SPONTANEOUS LOCOMOTION  
4.6.1 NET DISPLACEMENT 
After 15 days, the muscle strips of three 109 and 138 mJ/cm2 bio-bots incubated 
in DM(10%HS + ACA + IGF) began spontaneously twitching. An adequate number of 
cells in the muscle strip were contracting to move the pillars a discernible distance with 
each twitch. A camcorder was used to track the movement of the three bio-bots (hereafter 
referred to as 109, 138-1, and 138-2) across the surface of the tissue culture dish for 
observation periods ranging from 5-10 minutes (Figure 4.14A).  
 
 
Figure 4.14: Net locomotion. Camcorder (left, side-view) and microscope (right, top-view) images of the 
bio-bots moving across a surface due to spontaneous twitching of cells within the muscle strip. 
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All three bio-bots achieved net locomotion on days 15 and 16. The muscle strips 
from 109 and 138-1 broke after day 16, and the remaining measurements (days 17-19) 
are from 132-2 (which broke before imaging could be done on day 20) (Figure 4.15). 
Interestingly, all of the bio-bots displaced a greater distance per minute at later time 
points, likely due to increased maturation and force production capability of the cells 
within the muscle strip. No spontaneous twitching or net displacement was observed 
without IGF-I, i.e. from bio-bots cultured in DM(10%HS + ACA) through day 30; it is 
hypothesized that the myotubes in these muscle strips lagged behind those cultured with 
IGF-I in terms of maturation.  
Spontaneous contraction of differentiated skeletal muscle has been observed in 
many engineered muscle constructs, especially with the use of C2C12s. In many cases 
has been noted in the days following the addition of differentiation medium, and 
increased in the days thereafter (and generally after replacing the medium) (Bian & 
Bursac, 2009; Dennis et al., 2001; Hinds et al., 2011; Kosnik et al., 2001; Liao & Zhou, 
2009; Sakar et al., 2012). However, skeletal muscle, unlike cardiac or smooth muscle 
tissue, requires stimulus from a neuromuscular junction and does not inherently contract 
within the body. An action potential stimulates the release of calcium ions from the 
sarcoplasmic reticulum (SR), resulting in contraction until the active removal of calcium 
into the SR (Marieb, 2006). It is possible that the myotubes reached a state of early 
deterioration during the observation process (days 15-19) with increased intracellular 
calcium that resulted in spontaneous contraction after this time point. The integration of 
optogenetic regulation earlier in the differentiation process will allow a greater level of 
control over myotube contraction and movement of the bio-bot (see Section 5.1).  
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Figure 4.15: Net displacements. (A) Net displacements of all bio-bots (109, 138-1, and 138-2) over an 
observation period of 5-10 minutes from days 15-19. (B) Net displacements observed for each bio-bot 
individually. Generally, greater displacement per minute was observed at later time points.     
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4.6.2 VELOCITY 
To determine the velocities of the actuating bio-bots, still frames from each 
minute of observed locomotion were overlaid and the displacements were divided by the 
time interval. Average velocity was calculated as total displacement during observation 
divided by the total time of observation (Figure 4.16A). Maximum velocity was 
calculated with the maximum value of all distances traveled within a minute’s time 
(Figure 4.16B). As with the values of displacement, large variation can be seen in the 
velocities of the bio-bots, both across devices and over time. Although measurement 
conditions were kept as constant as possible, lack of consistency can be attributed to 
differences in cell distribution, temperature of the medium, and a geometric imbalance 
that prevented the force of contraction from overcoming the friction of the dish. The bio-
bot was fabricated as a symmetric design, but its asymmetry evolved over time due to 
non-uniform distribution of cells within the muscle strip. Improvements and future 
designs are discussed in Chapter 5. 
 
 
Figure 4.16: Average and Maximum Velocities. (A) Average speed (µm/min) of spontaneous actuating 
bio-bots from days 15-19. Bio-bot 138-2 continued to contract for three days after the muscle strips in 138-
1 and 109 broke. (B) Maximum velocities (µm/min) observed during one-minute intervals for actuating 
bio-bots. Inconsistency can be attributed to differences in cell distribution, temperature of the medium, and 
asymmetry that prevented the force of contraction from overcoming the friction of the dish.   
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4.6.3 FREQUENCY OF CONTRACTION 
The frequency of contractions was observed for bio-bot 138-2 on days 18 and 19 
by counting the number of visible contractions during 1-minute time intervals. (Note that 
this quantity does not represent individual myotube contractions, which could not be 
discerned using this method, but rather a sum of local contractions that globally produced 
enough force to move the pillars of the structure.) An approximate inverse relationship 
can be observed between the displacement and frequency (Figure 4.17). On both days, as 
the displacement increased, the frequency of contractions generally decreased. Although 
fresh warm (37ºC) media was added to each dish before recording started, it is likely that 
the temperature decreased below a physiological range over the span of 5-10 minutes. 
Recording the movement in a temperature-controlled chamber would eliminate this issue. 
  
 
Figure 4.17: Frequency of Contraction. (A) Net displacement and frequency (contractions per minute) of 
bio-bot 138-2 on day 18. (B) Net displacement and frequency (contractions per minute) of bio-bot 138-2 on 
day 19. The average observed frequency decreased, although the net displacement increased. Note the 
different scales of displacement values between (A) and (B).     
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5. CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 OPTOGENETIC CONTROL 
Over the past decade, a new method has harnessed the power of genetics and 
engineering to achieve cellular control. Engineers and biologists have turned to 
optogenetics (“Method of the Year” by Nature Methods in 2010, with over 23,000 
citations to date) as a remarkable and powerful cell perturbation tool (Entcheva, 2013). In 
addition to offering fast control over precisely defined events in a defined and targeted 
manner, optogenetics allows for cell-specific control with precise spatial and temporal 
targeting of biological systems in a reversible and non-invasive manner. No exogenous 
chemical is required, and many of the harmful consequences of electrical stimulation are 
eliminated (Deisseroth, 2012; Rein & Deussing, 2012).  We plan to use optogenetics in 
order to achieve control over the movement, pacing, and directionality of the bio-bots. 
The basis of optogenetic stimulation is the introduction of gain or loss of function 
of precisely defined events in a cell. These events are achieved through light-responsive 
ion channels called rhodopsins. Microbes lack complex eye structures; therefore, they 
have developed the use of light-activated rhodopsin proteins to respond to stimuli and 
maintain homeostatic balance. Rhodopsins are found in all kingdoms of life and are 
characterized by their “unitary nature:” a single gene encodes both the light-sensing and 
effector (ion flux) domains of the molecule (Fenno et al., 2011; Zhang et al., 2011). The 
formation of a functional rhodopsin complex requires retinal (a co-factor) to bind an 
opsin protein (Figure 5.1A). Binding of a photon results in isomerization and a 
subsequent conformational change of the opsin from trans to cis, enabling an ionic flow. 
The relative availability of retinal chromophores in vertebrate cells eliminates the need 
for an exogenous molecule to activate the ion channel (Pastrana, 2010).  
Channelrhodopsins are sensory photoreceptors with seven trans-membrane helical 
regions and a channel characterized by charged amino acid residues (Watanabe et al., 
2012). Channelrhodopsin-2 (ChR2) is a non-selective cation channel that responds to 
blue light (~480 nm) activation by permitting a passive influx of positive ions along a 
membrane gradient (Figure 5.1B). The subsequent depolarization of the cell (increase in 
voltage above the threshold for action potential generation) results in a “gain of function” 
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event (Fenno et al., 2011). ChR2 has a low selectivity among positive anions, but is not 
“unspecific” because it does not permit the conductance of anions across the membrane. 
The C2C12 skeletal muscle myoblasts used in this study have been transfected 
with ChR2. Preliminary experiments have shown contraction of the cells in response to 
blue light stimulation (data not shown). By selectively exciting the ChR2 C2C12s, the 
movement and pacing of the bio-bot could be achieved in a controlled manner. We 
believe this would also allow for earlier control in the lifetime of the muscle strips, i.e., 
before spontaneous contraction has been observed. 
Optogenetic tools can easily be delivered with viral gene transfer mechanisms 
(adeno-associated viruses and lentiviruses) or transgenic animal lines. In 2005, Boyden, 
Deisseroth and colleagues used ChR2 to stimulate rat neurons in the first demonstration 
that opsins could generate sufficient photocurrents for control of mammalian cells 
through membrane depolarization. The researchers also determined that expression of 
ChR2 did not alter the membrane characteristics or overall health of the cells (Boyden et 
al., 2005).  
Reports of optogenetic muscle cells have lagged behind neuroscientific studies by 
about half a decade. Optogenetic control of heart muscle was achieved by Bruegmann et 
al. with a transgenic mouse embryonic stem cell (ESC) line that expressed a mutant form 
of ChR2 differentiated through the formation of embryoid bodies (EBs) to form 
cardiomyocytes. Optical stimulation of one region of a ChR2-expressing cardiomyocyte 
layer was followed by activity in other regions through spreading of the electrical signal 
across cell junctions, demonstrating the potential of a pacemaker site. Finally, transgenic 
mice with ventricular cardiomyocytes expressing ChR2 were intubated and the beating 
hearts were illuminated with blue light. An ECG recorded supraventricular pacing of the 
heart in response to the pulsed optical stimulation. Traditional electrical stimulation of 
cardiac muscle is irreversibly damaging, inhomogeneous, and unable to induce lengthy 
depolarizations (Bruegmann et al., 2010). Arrenberg and colleagues expressed ChR2 and 
NpHR in zebrafish cardiomyocytes to stimulate various cardiac events such as 
tachycardia, atrioventricular blocks, and cardiac arrest. Contractions were almost 
instantaneously blocked by NpHR stimulation and reversibly recovered when the 
illumination was removed (Arrenberg et al., 2010).  
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Figure 5.1: Optogenetics. (A) An opsin protein binds the co-factor retinal to become all-trans rhodopsin.  
Photon absorption induces a conformational change to a cis formation, and an ionic flow is established 
across the membrane. (B) & (C) Various rhodopsins have a range of spectral profiles permit the flow of 
positive and negative ions (Rein et al, 2012) (D) Displacement of a pair of cantilevers surrounded by 
optogenetic C2C12s is controlled by the cells’ response to blue light (Sakar et al., 2012)  
Asano and colleagues published one of the first reports of photosensitive skeletal 
muscle cell control. A blue-light LED with a power density of 0.12 mW/mm2 was used to 
optically stimulate ChR2-transfected C2C12 myotubes in one of the first.  A muscle cell 
twitch was observed for pulses at frequencies between 1-4 Hz; above 5Hz, the effect 
varied among myotubes. For some myotubes, however, no amount of stimulation strength 
could induce an action potential (Asano et al., 2012). Sakar et al. seeded ChR2-
expressing C2C12s into PDMS microwells with collagen and Matrigel, applied 20 ms 
blue light pulses, and measured the displacement of attached cantilevers. This method 
demonstrated not only a novel bioactuator technology but also the ability to control its 
stimulation and movement in a specific manner (Figure 5.1D, Section 2.4.3) (Sakar et al., 
2012).  
Halorhodopsin is structurally homologous to ChR2, but fundamentally different in 
its working principle. In contrast to channelrhodopsins, halorhodopsins are chloride 
pumps that inhibit an action potential (Figure 5.1B). Influx of negative ions into induces 
hyperpolarization of the membrane (and subsequent silencing of the cell) with yellow 
light activation (~589 nm). Halorhodopsin must work against an electrochemical gradient 
 58 
to pump ions across the membrane (Rein & Deussing, 2012). Zhang and members of the 
same team combined ChR2 with a halorhodopsin chloride pump (NpHR) sensitive to 
yellow light). Addition of this hyperpolarizing ion channel allowed for an inhibition to 
complement ChR2 in a multimodal, bi-directional targeting system of neuronal circuits. 
The spectral separation between ChR2 and NpHR (~100 nm) allowed the two events to 
be conducted separately or together. Fusion of ChR2/NpHR was examined in body wall 
muscles of a transgenic nematode (C. elegans), with NpHR effectively countering the 
activity from ChR2 (Zhang et al., 2007). Eventually, we desire to achieve multimodal 
ON/OFF control of C2C12-based bio-bots with the incorporation of NpHR as well as 
ChR2. The bio-bot could be stimulated to begin contracting with blue light, and forced to 
halt with yellow light.   
5.2 OPTIMIZATION AND BIO-INSPIRED DESIGNS  
The current design of the bio-bot does not permit optimized locomotion due to 
many factors. The first is the geometric set-up. Although inherently asymmetric due to a 
non-uniform distribution of cells within the muscle strip and unbalanced placement of the 
pillars, the original design assumes a balanced arrangement of muscle strip surrounding 
equidistant pillars. The proof-of-concept design was inspired by published reports of 
micro-tissue cantilever force measurement devices (Boudou et al., 2012; Sakar et al., 
2012). Therefore, the introduction of deliberate asymmetry (either by extending the 
length of one of the pillars or ensuring localization of skeletal muscle cells on one side of 
the muscle strip) would likely result in greater displacements and velocities of the device 
across a surface. 
Additionally, the incorporation of multiple muscle strips into a “multi-legged” 
design (with each “leg” comprised of a muscle strip surrounding two pillars) would allow 
for directional control over the bio-bot’s movement.  Blue-light stimulation of one “leg” 
would result in displacement in a specified direction; the bio-bot could change directions 
with the application of blue light to an opposing “leg” (Figure 5.2). 
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Figure 5.2: Multi-legged designs. (A) AutoCAD rendering of 4-legged bio-bot. (B) Actual image of 
muscle strip compaction around 4-legged bio-bot. (C) AutoCAD rendering of “spider” 8-legged device. 
 
Finally, the output of the bio-bot could be improved by improving the 
organization and functionality of the skeletal muscle. Despite the recent advances in this 
field, some challenges remain: first, the fabrication of muscle tissue that exhibits proper 
alignment and architecture, i.e. myofibers that are densely arranged and aligned in a large 
volume. Lam et al. devised a method to develop pre-aligned muscle constructs by 
patterning topographical features on a PDMS substrate.  Myoblasts were seeded on the 
PDMS surface, differentiated, and covered with a tin layer of fibrin.  The cells self-
organized by rolling up into 3D constructs and began to degrade the fibrin matrix over 
time. The functional force production from aligned constructs was more than doubled 
compared to the unaligned control (Lam et al., 2009). A method to increase alignment in 
the muscle strips would most likely increase the force production and net locomotion of 
the device.  
Depriving metabolic tissues of nutrients and oxygen can lead to necrosis on the 
inside of the tissue (i.e., more than couple of hundred microns from the edge), as 
fluorescent imaging has demonstrated. The use of hydrogels as a support platform can 
help to alleviate some issues, as they can provide an environment compatible with cell 
alignment and organization (Bian & Bursac, 2008; Khodabukus & Baar, 2009). Fibrin is 
a natural hydrogel, but perhaps the composition of the matrix can be optimized to find the 
conditions that allow for the metabolic needs of the tissue. 
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5.3 MICROSTEREOLITHOGRAPHY SYSTEM 
A micro-stereolithography system is currently being developed for two purposes: 
first, creating bio-bots with smaller features, and second, as a platform for selectively 
stimulating individual cells or cell clusters within the muscle strip. Micro-
stereolithography is a “top-down” fabrication approach that uses a projected light system 
and a digital micro-mirror device (DMD) or liquid crystal display (LCD) as a dynamic 
mask (Cho & Kang, 2012). A DMD is an array of individual micro-mirrors that can be 
switched on or off for every pixel. In contrast to traditional stereolithography, re-coating 
of the surface is not necessarily required, the illuminated surface is smooth, and oxygen 
inhibition is limited because the layer being polymerized is not in contact with the 
atmosphere (Melchels et al., 2010). The yield is increased by a decreased fabrication 
time; instead of using a scanning laser, the entire layer is cured at once by the projection 
of a 2D pattern onto a transparent platform. 
Light for optogenetic stimulation can be delivered through filtered mercury 
lamps, lasers, LEDs or LED arrays (for multi-site stimulation), as well as optical fibers 
transmitting laser light through cannulas for in vivo studies. A DMD or two-photon 
confocal microscope can be used to control the pattern of light on specific cells or regions 
to selectively stimulate a subset of excitable cells or part of the cells (Fenno et al., 2011; 
Pastrana, 2010). Manipulation of light on a millisecond-scale light (a range relevant for 
action potentials and other events of excitable cells) is required, and Zhang et al. reported 
a minimum power density of 5-12 mW/mm2 for photoactivation (Zhang et al., 2006).   
5.4 A COMPLETE CELLULAR SYSTEM 
The integration with other cell types and subsequent vascularization for long-term 
survival and metabolic activity is necessary to sustain muscle cell contraction. The 
critical interfaces of skeletal muscle are myotendious (mechanical), vascular (chemical), 
and neuromuscular (sensory and control).  
The “biological parts” comprising many higher-level systems have been 
assembled to date as individual machine components with one or two cell types. Muscle 
cells have been used for biological actuators and neurons or neuronal networks assemble 
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into sensory clusters or processors. The challenge, then, is to coordinate the cell types in a 
way that allows for new functionalities and applications in various fields. A complete 
cellular system needs many different components in order to be self-sustaining and 
autonomous: muscle cells that allow for movement, neuromuscular junctions to interface 
between muscle and neurons for control and processing, a vasculature supported by 
endothelial cells to provide nutrients and oxygen, and an exoskeleton for long-term 
viability and protection.  
Integration of muscle, nature’s own actuator, with optogenetic control, a wireless 
driver of functional outputs, would truly create a biological “machine”.  The addition of 
other cell types for these functional characteristics will only further define the biological 
machines of the future. 
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